<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.1d2 20140930//EN" "JATS-archivearticle1.dtd"> 
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article"><?properties open_access?><?DTDIdentifier.IdentifierValue -//Springer-Verlag//DTD A++ V2.4//EN?><?DTDIdentifier.IdentifierType public?><?SourceDTD.DTDName A++V2.4.dtd?><?SourceDTD.Version 2.4?><?ConverterInfo.XSLTName springer2nlmx2.xsl?><?ConverterInfo.Version 2?><front><journal-meta><journal-id journal-id-type="nlm-ta">BMC Genomics</journal-id><journal-id journal-id-type="iso-abbrev">BMC Genomics</journal-id><journal-title-group><journal-title>BMC Genomics</journal-title></journal-title-group><issn pub-type="epub">1471-2164</issn><publisher><publisher-name>BioMed Central</publisher-name><publisher-loc>London</publisher-loc></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">4359779</article-id><article-id pub-id-type="publisher-id">1358</article-id><article-id pub-id-type="doi">10.1186/s12864-015-1358-y</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group></article-categories><title-group><article-title>Analysis of RNA decay factor mediated RNA stability contributions on RNA abundance</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Maekawa</surname><given-names>Sho</given-names></name><address><email>smaekawa@hgc.jp</email></address><xref ref-type="aff" rid="Aff1"/></contrib><contrib contrib-type="author"><name><surname>Imamachi</surname><given-names>Naoto</given-names></name><address><email>imamachi@ric.u-tokyo.ac.jp</email></address><xref ref-type="aff" rid="Aff2"/></contrib><contrib contrib-type="author"><name><surname>Irie</surname><given-names>Takuma</given-names></name><address><email>tirie@hgc.jp</email></address><xref ref-type="aff" rid="Aff1"/></contrib><contrib contrib-type="author"><name><surname>Tani</surname><given-names>Hidenori</given-names></name><address><email>h.tani@aist.go.jp</email></address><xref ref-type="aff" rid="Aff3"/></contrib><contrib contrib-type="author"><name><surname>Matsumoto</surname><given-names>Kyoko</given-names></name><address><email>kk086409@mgs.k.u-tokyo.ac.jp</email></address><xref ref-type="aff" rid="Aff1"/></contrib><contrib contrib-type="author"><name><surname>Mizutani</surname><given-names>Rena</given-names></name><address><email>rena@ric.u-tokyo.ac.jp</email></address><xref ref-type="aff" rid="Aff2"/></contrib><contrib contrib-type="author"><name><surname>Imamura</surname><given-names>Katsutoshi</given-names></name><address><email>k.imamura@ric.u-tokyo.ac.jp</email></address><xref ref-type="aff" rid="Aff2"/></contrib><contrib contrib-type="author"><name><surname>Kakeda</surname><given-names>Miho</given-names></name><address><email>3134mk@gmail.com</email></address><xref ref-type="aff" rid="Aff2"/></contrib><contrib contrib-type="author"><name><surname>Yada</surname><given-names>Tetsushi</given-names></name><address><email>ytetsu@bio.kyutech.ac.jp</email></address><xref ref-type="aff" rid="Aff4"/></contrib><contrib contrib-type="author"><name><surname>Sugano</surname><given-names>Sumio</given-names></name><address><email>ssugano@k.u-tokyo.ac.jp</email></address><xref ref-type="aff" rid="Aff1"/></contrib><contrib contrib-type="author" corresp="yes"><name><surname>Suzuki</surname><given-names>Yutaka</given-names></name><address><email>ysuzuki@k.u-tokyo.ac.jp</email></address><xref ref-type="aff" rid="Aff1"/><xref ref-type="aff" rid="Aff5"/></contrib><contrib contrib-type="author" corresp="yes"><name><surname>Akimitsu</surname><given-names>Nobuyoshi</given-names></name><address><email>akimitsu@ric.u-tokyo.ac.jp</email></address><xref ref-type="aff" rid="Aff2"/></contrib><aff id="Aff1"><label/>Department of Medical Genome Sciences, Graduate School of Frontier Sciences, The University of Tokyo, 5-1-5 Kashiwanoha, Kashiwa, Chiba 277-8562 Japan </aff><aff id="Aff2"><label/>Radioisotope Center, The University of Tokyo, 2-11-16 Yayoi, Bunkyo-ku, Tokyo 113-0032 Japan </aff><aff id="Aff3"><label/>Research Institute for Environmental Management Technology, National Institute of Advanced Industrial Science and Technology (AIST), 16-1 Onogawa, Tsukuba, Ibaraki 305-8569 Japan </aff><aff id="Aff4"><label/>Department of Bioscience and Bioinformatics, Kyushu Institute of Technology, 680-4 Kawazu, Iizuka, Fukuoka 820-8502 Japan </aff><aff id="Aff5"><label/>Department of Computational Biology, Graduate School of Frontier Sciences, The University of Tokyo, 5-1-5 Kashiwanoha, Kashiwa, Chiba 277-8561 Japan </aff></contrib-group><pub-date pub-type="epub"><day>6</day><month>3</month><year>2015</year></pub-date><pub-date pub-type="pmc-release"><day>6</day><month>3</month><year>2015</year></pub-date><pub-date pub-type="collection"><year>2015</year></pub-date><volume>16</volume><issue>1</issue><elocation-id>154</elocation-id><history><date date-type="received"><day>19</day><month>5</month><year>2014</year></date><date date-type="accepted"><day>19</day><month>2</month><year>2015</year></date></history><permissions><copyright-statement>&#x000a9; Maekawa et al.; licensee BioMed Central. 2015</copyright-statement><license license-type="open-access"><license-p>This is an Open Access article distributed under the terms of the Creative Commons Attribution License (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0">http://creativecommons.org/licenses/by/4.0</ext-link>), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/publicdomain/zero/1.0/">http://creativecommons.org/publicdomain/zero/1.0/</ext-link>) applies to the data made available in this article, unless otherwise stated.</license-p></license></permissions><abstract id="Abs1"><sec><title>Background</title><p>Histone epigenome data determined by chromatin immunoprecipitation sequencing (ChIP-seq) is used in identifying transcript regions and estimating expression levels. However, this estimation does not always correlate with eventual RNA expression levels measured by RNA sequencing (RNA-seq). Part of the inconsistency may arise from the variance in RNA stability, where the transcripts that are more or less abundant than predicted RNA expression from histone epigenome data are inferred to be more or less stable. However, there is little systematic analysis to validate this assumption. Here, we used stability data of whole transcriptome measured by 5&#x02032;-bromouridine immunoprecipitation chase sequencing (BRIC-seq), which enabled us to determine the half-lives of whole transcripts including lincRNAs, and we integrated BRIC-seq with ChIP-seq to achieve better estimation of the eventual transcript levels and to understand the importance of post-transcriptional regulation that determine the eventual transcript levels.</p></sec><sec><title>Results</title><p>We identified discrepancies between the RNA abundance estimated by ChIP-seq and measured RNA expression from RNA-seq; for number of genes and estimated that the expression level of 865 genes was controlled at the level of RNA stability in HeLa cells. ENCODE data analysis supported the idea that RNA stability control aids to determine transcript levels in multiple cell types. We identified UPF1, EXOSC5 and STAU1, well-studied RNA degradation factors, as controlling factors for 8% of cases. Computational simulations reasonably explained the changes of eventual mRNA levels attributable to the changes in the rates of mRNA half-lives. In addition, we propose a feedback circuit that includes the regulated degradation of mRNAs encoding transcription factors to maintain the steady state level of RNA abundance. Intriguingly, these regulatory mechanisms were distinct between mRNAs and lincRNAs.</p></sec><sec><title>Conclusions</title><p>Integrative analysis of ChIP-seq, RNA-seq and our BRIC-seq showed that transcriptional regulation and RNA degradation are independently regulated. In addition, RNA stability is an important determinant of eventual transcript levels. RNA binding proteins, such as UPF1, STAU1 and EXOSC5 may play active roles in such controls.</p></sec><sec><title>Electronic supplementary material</title><p>The online version of this article (doi:10.1186/s12864-015-1358-y) contains supplementary material, which is available to authorized users.</p></sec></abstract><kwd-group xml:lang="en"><title>Keywords</title><kwd>BRIC-seq</kwd><kwd>ChIP-seq</kwd><kwd>Integrative analysis</kwd><kwd>Next-generation sequencing</kwd><kwd>RNA stability</kwd><kwd>Estimation of transcriptional level</kwd></kwd-group><custom-meta-group><custom-meta><meta-name>issue-copyright-statement</meta-name><meta-value>&#x000a9; The Author(s) 2015</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec id="Sec1"><title>Background</title><p>The eventual RNA transcript level of a gene is determined by regulation at multiple levels, including transcriptional initiation, elongation, splicing, export and degradation. Transcription initiation is regulated by complex interactions of sequence features, many of which involve chromatin modifications [<xref ref-type="bibr" rid="CR1">1</xref>]. Although it is still unclear whether chromatin modifications are the cause or consequence of transcription, these chromatin modifications are often used to infer transcriptional regulation. The chromatin modifications include several types of histone modifications, such as H3K4 tri-methylation (H3K4me3), which is often observed around the transcriptional start sites of actively transcribed transcripts [<xref ref-type="bibr" rid="CR2">2</xref>,<xref ref-type="bibr" rid="CR3">3</xref>]. In several large-scale projects they often used H3K4me3 sites as markers for active transcription, which allowed the characterization of transcriptionally active regions and estimation of transcript levels in a given cell at a given state [<xref ref-type="bibr" rid="CR4">4</xref>]. This partly reflects the fact that advances in next generation sequencing have enabled easy characterization of the sites bound by H3K4me3 sites using chromatin immunoprecipitation sequencing (ChIP-seq) [<xref ref-type="bibr" rid="CR5">5</xref>]. Indeed, a recent ENCODE study conducted a large number of ChIP-seq experiments in difference cell types. There have been several papers that modeled gene expression levels from chromatin features [<xref ref-type="bibr" rid="CR4">4</xref>,<xref ref-type="bibr" rid="CR6">6</xref>,<xref ref-type="bibr" rid="CR7">7</xref>]. It is evident that ChIP-seq data is not sufficient enough to model the steady-state RNA expression levels for a number of genes, and regulatory mechanisms other than transcription initiation needs to be considered to understand the RNA expression.</p><p>RNA degradation is regulated by degradation factor, such as UPF1, EXOSC5 and STAU1, through RNA-protein and protein-protein interactions. UPF1 is an essential mediator in nonsense-mediated mRNA decay (NMD), in which aberrant RNA containing a premature stop-codon (PTC) is recognized and degraded [<xref ref-type="bibr" rid="CR8">8</xref>-<xref ref-type="bibr" rid="CR10">10</xref>]. In addition, recent genome-wide analyses by microarrays and RNA-seq have suggested a regulatory role for UPF1 in targeting 3-20% of <italic>bona fide</italic> mRNA with full coding potential [<xref ref-type="bibr" rid="CR11">11</xref>-<xref ref-type="bibr" rid="CR15">15</xref>]. UPF1 is involved in other degradation pathways such as the Staufen1-mediated mRNA decay (SMD) and replication-dependent histone mRNA decay [<xref ref-type="bibr" rid="CR16">16</xref>,<xref ref-type="bibr" rid="CR17">17</xref>]. It was proposed that approximately 1% of human mRNAs are regulated by Staufen1 (STAU1), suggesting that SMD constitutes a significant post-transcriptional regulatory pathway [<xref ref-type="bibr" rid="CR18">18</xref>]. EXOSC5 is the essential component of the exosome complex, which functions in 3&#x02032; &#x02013; 5&#x02032; RNA degradation [<xref ref-type="bibr" rid="CR19">19</xref>,<xref ref-type="bibr" rid="CR20">20</xref>]. However, even for these well-known factors, it is still unclear as to what extent they effect the eventual transcript levels.</p><p>In this study, we generated and integrated a dataset of BRIC-seq [<xref ref-type="bibr" rid="CR21">21</xref>,<xref ref-type="bibr" rid="CR22">22</xref>], RNA-seq and ChIP-seq, in order to uncover the contributions of RNA decay in determining eventual genome-wide transcript levels [<xref ref-type="bibr" rid="CR23">23</xref>]. In BRIC-seq, the half-lives of transcripts are measured using 5&#x02032;-bromouridine (BrU) based <italic>in situ</italic> labeling of RNA. BrU added in culture medium is incorporated into cells, which convert it to BrUTP. It is incorporated into nascent RNA during transcription, and consequently, endogenous RNAs are labeled with BrU. BrU-labeled total RNAs are isolated from cells at sequential time points after removal of surplus BrU from the culture medium. BrU-labeled RNAs are recovered by immunopurification followed by analysis by massive sequencing. By this method, we can avoid artificial effects of the traditionally used transcriptional inhibitor, such as actinomyicin D, method, in which the physiology of the cell is known to be greatly affected [<xref ref-type="bibr" rid="CR22">22</xref>]. Although 5&#x02032;-ethynyl uridine labeling and 4&#x02032;-thiouridine labeling methods have been used for measuring the transcriptome stability, these nucleotide analogues are more toxic than BrU. BrU therefore has an advantage to determine RNA stabilities in physiologically non-disturbed conditions. It has been known that the RNA abundance does not necessarily correlate with their transcription rates; however the reasoning behind the lack of correlation, have not been well characterized. Here we identified genes that have low RNA abundance that could be explained by a particular RNA half-life. In addition, with the aid of computational simulation, we identified genes with RNA abundance that was mediated by changes in RNA stability by RNA decay factors: UPF1, EXOSC5, and STAU1.</p></sec><sec id="Sec2" sec-type="results"><title>Results</title><sec id="Sec3"><title>Correlation between ChIP-seq and RNA-seq data</title><p>First we analyzed the relationship between levels of the transcripts and the strength of active chromatin marks by performing ChIP-seq (chromatin immunoprecipitation) analysis of H3K4me3 and pol II on the Illumina HiSeq2000 platform. ChIP-seq peaks were called using a representative analytical program, MACS [<xref ref-type="bibr" rid="CR24">24</xref>], using the default parameters (false discovery rate of p&#x02009;&#x0003c;&#x02009;10<sup>&#x02212;5</sup>). For the transcript levels, we used RNA-seq to determine the genome-wide gene expression in HeLa cells and we analyzed RNA-seq by modeling the gene to the Refseq gene model (for statistics, see Additional file <xref rid="MOESM1" ref-type="media">1</xref>: Figure S1).</p><p>We identified a total of 11,116 (2,732 with low peak and 8,384 with high peak) and 6,319 genes that possessed H3K4me3 and pol II &#x0201c;peak&#x0201d;, respectively, within the 3&#x000a0;kb regions around transcriptional start sites (+/&#x02212;1.5 kbp, with transcriptional start sites designated as 0), out of 18,853 RefSeq genes analyzed (Table&#x000a0;<xref rid="Tab1" ref-type="table">1</xref>, Additional file <xref rid="MOESM1" ref-type="media">1</xref>: Figure S1a and Additional file <xref rid="MOESM2" ref-type="media">2</xref>: Table S1). In the cases where the peaks were not identified, the ChIP-seq tags were mostly at the noise level; if peaks were identified, we associated the signal intensities of ChIP-seq of H3K4me3 and RNA-seq gene expression levels (in RPKM) to the gene. We observed genes possessing more than 1&#x02009;&#x000d7;&#x02009;10<sup>4</sup> H3K4me3 sequence tags and pol II peaks (&#x0201c;high peaks&#x0201d; group showed RNA level of &#x0003e;1 and &#x0003e;10 RPKM in 7,656 (73.5%) and 4,073 (84.0%) cases, among 10,421 and 3,069 genes with pol II peaks respectively (Table&#x000a0;<xref rid="Tab1" ref-type="table">1</xref> and Additional file <xref rid="MOESM2" ref-type="media">2</xref>: Table S1).<table-wrap id="Tab1"><label>Table 1</label><caption><p><bold>Statistics of H3K4me3 ChIP-seq peaks against gene expression</bold>
</p></caption><table frame="hsides" rules="groups"><thead><tr valign="top"><th/><th>
<bold>Total</bold>
</th><th>
<bold>No peak</bold>
</th><th>
<bold>Low Peak</bold>
</th><th>
<bold>High Peak</bold>
</th></tr></thead><tbody><tr valign="top"><td>
<bold>Number of Genes</bold>
</td><td>
<bold>18,853</bold>
</td><td>
<bold>7,737</bold>
</td><td>
<bold>2,732</bold>
</td><td>
<bold>8,384</bold>
</td></tr><tr valign="top"><td>
<bold>Genes having RNA level of &#x0003e;1 RPKM</bold>
</td><td>
<bold>10,421</bold>
</td><td>
<bold>957</bold>
</td><td>
<bold>1,808</bold>
</td><td>
<bold>7,656</bold>
</td></tr><tr valign="top"><td>
<bold>Genes having RNA level of &#x0003e;10 RPKM</bold>
</td><td>
<bold>4,848</bold>
</td><td>
<bold>175</bold>
</td><td>
<bold>600</bold>
</td><td>
<bold>4,073</bold>
</td></tr></tbody></table><table-wrap-foot><p>Peaks were called using MACS and &#x0201c;peak present&#x0201d; represents genes with H3K4me3 and pol II peaks within 1.5&#x000a0;kb of the TSS (details in <xref rid="Sec12" ref-type="sec">Methods</xref>). &#x0201c;No peak&#x0201d; represents genes without any H3K4me3 or pol II peaks within 1.5&#x000a0;kb of the TSS.</p></table-wrap-foot></table-wrap></p><p>We quantitatively analyzed the correlation between ChIP-seq and RNA-seq data for genes with ChIP-seq &#x0201c;peaks&#x0201d;. As shown in Figure&#x000a0;<xref rid="Fig1" ref-type="fig">1</xref>a, we observed a positive correlation; mRNAs with higher expression levels were associated with higher ChIP-seq signal intensities, and we observed Pearson&#x02019;s correlation of R&#x02009;=&#x02009;0.71 (p-value&#x02009;&#x0003c;&#x02009;2.2&#x02009;&#x000d7;&#x02009;10<sup>&#x02212;16</sup>) with a log-transformed scatterplot (Figure&#x000a0;<xref rid="Fig1" ref-type="fig">1</xref>b). When we examined individual genes, it was often possible to observe active transcription with large H3K4me3 ChIP-seq peaks, which is shown in Figure&#x000a0;<xref rid="Fig1" ref-type="fig">1</xref>c. In contrast, we observed a number of cases in which RNA expression was insignificant, despite significant chromatin marks, as shown in Figure&#x000a0;<xref rid="Fig1" ref-type="fig">1</xref>d. A significant population deviated from the straightforward expected distributions in Figure&#x000a0;<xref rid="Fig1" ref-type="fig">1</xref>b. When we set the threshold of more than 1&#x02009;&#x000d7;&#x02009;10<sup>4</sup> for H3K4me3 ChIP-seq intensity, presence of polII ChIP-seq and less than 10 RPKM for RNA expression, we identified 2,861, genes (ChIP (+)/RNA (&#x02212;): upper left corner in Figure&#x000a0;<xref rid="Fig1" ref-type="fig">1</xref>b) in which significant levels of ChIP-seq peaks and low levels of RNA-seq were detected, as shown in Figure&#x000a0;<xref rid="Fig1" ref-type="fig">1</xref>d. In addition, for 2,897 genes (ChIP (&#x02212;)/RNA (+): bottom right corner in Figure&#x000a0;<xref rid="Fig1" ref-type="fig">1</xref>b), although ChIP-seq intensities were less than 1&#x02009;&#x000d7;&#x02009;10<sup>&#x02212;4</sup> for H3K4me3 and no polII ChIP-seq peaks were detected, RNA-seq indicated significant RNA levels of more than 10 RPKM, as shown in Figure&#x000a0;<xref rid="Fig1" ref-type="fig">1</xref>e. Thus, we identified discrepancies between the ChIP-seq data and the RNA-seq data for a significant population of genes.<fig id="Fig1"><label>Figure 1</label><caption><p>
<bold>Relationship between chromatin marks and eventual transcript levels. (a)</bold> Boxplot of the intensities for the ChIP-seq peaks of H3K4me3. Intensities are plotted for the populations with different expression levels measured by RNA-seq and are indicated on the x-axis (Gene Expression Values). Asterisks indicate statistically significant differences, as evaluated by Wilcoxon&#x02019;s singed rank test (P-values, ***<italic>P</italic>&#x02009;&#x0003c;&#x02009;0.001). <bold>(b)</bold> Scatterplot representing the ChIP-seq peak signal intensities of H3K4me3 on the y-axis and gene expression values on the x-axis (n&#x02009;=&#x02009;6,105). Pearson&#x02019;s correlation co-efficiencies of the plots (R&#x02009;=&#x02009;0.71) are also shown in the graph area. Dotted lines on the x-axis show 10 RPKM and y-axis show 1&#x02009;&#x000d7;&#x02009;10<sup>4</sup> H3K4me3 intensities. Labels on each quadrant of the graph (e.g., ChIP (+) / RNA (&#x02212;)) are the names given to these set of genes, and are used continually throughout this manuscript. <bold>(c, d, e)</bold> Graphical representation of the patterns of ChIP-seq (H3K4me3 and pol II) and RNA-seq data for the RSP8 gene <bold>(c)</bold>, PTGS2 gene <bold>(d)</bold> and NES gene <bold>(e)</bold>. Arrows indicate the direction of transcription and N/A indicates the lack of recognized peaks by MACS. Note that while the ChIP-seq of H3K4me3 and pol II consistently indicate active gene expression of RSP8 and PTGS2 genes, essentially no gene expression was observed for PTGS2 <bold>(d)</bold>. For the NES gene, RNA-seq tags were observed despite the lack of ChIP-seq signals of H3K4me3 and pol II.</p></caption><graphic xlink:href="12864_2015_1358_Fig1_HTML" id="MO1"/></fig></p></sec><sec id="Sec4"><title>Correlation among half-lives of the transcripts, chromatin marks and transcript levels</title><p>To examine the cause of the discrepancy, we focused on mRNA stabilities. We used our unique method, BRIC-seq, in which the nascent RNAs are labeled with 5&#x02032;-bromouridine (BrU) and subjected to massive sequencing analysis in a time-lapse manner. By calculating the number of BrU-labeled RNA tags that remain in the population after a particular time duration, BRIC-seq can be used to measure each RNA half-life at a genome-wide level [<xref ref-type="bibr" rid="CR21">21</xref>,<xref ref-type="bibr" rid="CR22">22</xref>]. Detailed sequencing statistics for representative cases are shown in Additional file <xref rid="MOESM1" ref-type="media">1</xref>: Figure S1.</p><p>We examined the relationship between the eventual mRNA levels and the half-lives for genes with ChIP-seq &#x0201c;peaks&#x0201d;, which reflect active transcriptional initiation. In these cases, we observed positive correlation (Figure&#x000a0;<xref rid="Fig2" ref-type="fig">2</xref>a), in which the half-lives of the transcripts were shorter in proportion to the decreasing expression levels. However, we detected no correlations between the half-lives of the mRNAs with the ChIP-seq intensities (Figure&#x000a0;<xref rid="Fig2" ref-type="fig">2</xref>b). These results indicate that RNA stability may be a contributing factor for the determination of eventual transcript levels. Furthermore, the mRNA stability control is independent of transcriptional initiation, which is inferred by chromatin states.<fig id="Fig2"><label>Figure 2</label><caption><p>
<bold>Relationships between RNA half-lives, transcript levels and chromatin marks. (a)</bold> Boxplot chart of the RNA half-lives of mRNAs of varying expression levels. <bold>(b)</bold> Boxplot charts of the signal intensities for the ChIP-seq peaks plotted for gene populations with different RNA half-lives, as indicated on the x-axis. <bold>(c)</bold> Boxplot chart of the half-life distributions in different ChIP-seq and RNA-seq fractions. Labels on the x-axis refer to the quadrant from Figure&#x000a0;<xref rid="Fig1" ref-type="fig">1</xref>b. For ChIP (+) / RNA (+), &#x02018;total&#x02019; indicates the total transcripts, and &#x02018;&#x000d7;2&#x02019; and &#x02018;&#x000d7;1.1&#x02019; indicates all the genes within 2-fold (green dots in Figure&#x000a0;2d) and 1.1-fold (red dots in Figure&#x000a0;2d) of the least squared regression line, respectively. Asterisks in <bold>(a&#x02013;c)</bold> indicate statistical significance by Wilcoxon&#x02019;s signed rank test (P-values *<italic>P</italic>&#x02009;&#x0003c;&#x02009;0.05, **<italic>P</italic>&#x02009;&#x0003c;&#x02009;0.01, ***<italic>P</italic>&#x02009;&#x0003c;&#x02009;0.001). <bold>(d)</bold> Scatterplot to show the distributions of ChIP (+) / RNA (+) genes. Line is the least squared regression line. Red and green dots indicate genes within 1.1-fold and 2-fold of the least squared regression line, respectively. <bold>(e)</bold> Scatterplot representing the ChIP-seq peak signal intensities of H3K4me3 on the y-axis and gene expression values on the x-axis for transcripts with ChIP-seq peaks and measured half-lives (total n&#x02009;=&#x02009;12,479). Genes having &#x0201c;short&#x0201d; (t<sub>1/2</sub>&#x02009;&#x0003c;&#x02009;4&#x000a0;h) half-lives (short n&#x02009;=&#x02009;3190) are indicated in red dots and were statistically significant (p-value 6.8&#x02009;&#x000d7;&#x02009;10<sup>&#x02212;16</sup>). Dotted lines show the 10 RPKM and 1&#x02009;&#x000d7;&#x02009;10<sup>4</sup> peak intensities.</p></caption><graphic xlink:href="12864_2015_1358_Fig2_HTML" id="MO2"/></fig></p><p>Based on these observations, we speculated that control of the stability of mRNAs might play a pivotal role in determining the eventual RNA levels, particularly in case in which the ChIP-seq and RNA-seq data were inconsistent (ChIP (+)/RNA (&#x02212;) population in Figure&#x000a0;<xref rid="Fig1" ref-type="fig">1</xref>b); where, the transcript levels may be suppressed at a low level, despite their active transcription, owing to fast RNA turnover rates. To examine this possibility, we compared the half-lives of mRNAs between gene groups having H3K4me3 ChIP-seq intensities of more than 1&#x02009;&#x000d7;&#x02009;10<sup>4</sup>, a presence of polII ChIP-seq peak, with gene expression levels below 10 RPKM (ChIP (+)/RNA (&#x02212;)) and those with H3K4me3 ChIP-seq intensities higher than 1&#x02009;&#x000d7;&#x02009;10<sup>4</sup>, with a presence of polII ChIP-seq peak and gene expression values above 10 RPKM (ChIP (+)/RNA (+)) or those with H3K4me3 ChIP-seq intensities lower than 1&#x02009;&#x000d7;&#x02009;10<sup>4</sup>, with a lack of polII ChIP-seq peak and gene expression values above 10 RPKM (ChIP (&#x02212;)/RNA (+)), genes that half-lives could be measured. As shown in Figure&#x000a0;<xref rid="Fig2" ref-type="fig">2</xref>c, we found that half-lives of the transcripts for ChIP (+)/RNA (&#x02212;) genes were significantly shorter than those of ChIP (+)/RNA (+) genes (p value&#x02009;&#x0003c;&#x02009;2.2&#x02009;&#x000d7;&#x02009;10<sup>&#x02212;16</sup>) and ChIP (&#x02212;)/RNA (+) genes (p value&#x02009;&#x0003c;&#x02009;2.2&#x02009;&#x000d7;&#x02009;10<sup>&#x02212;16</sup>). From the correlations between RNA-seq and ChIP-seq as shown in Figure&#x000a0;<xref rid="Fig1" ref-type="fig">1</xref>b, it was possible to infer the gene expression levels from the ChIP-seq intensities for those genes in which the RNA-seq and ChIP-seq were consistent. When we examined genes for which gene expression values were within a 2 or 1.1 fold difference from those expected from the ChIP-seq intensities (Figure&#x000a0;<xref rid="Fig2" ref-type="fig">2</xref>d), we observed narrower distribution of the mRNA half-lives with a median value of 11.0 and 10.9&#x000a0;hours, respectively (Figure&#x000a0;<xref rid="Fig1" ref-type="fig">1</xref>c and Table&#x000a0;<xref rid="Tab2" ref-type="table">2</xref>). These half-lives of ChIP (+)/RNA (+) genes may serve as the default half-lives of those genes, and if genes do exhibit this particular mRNA half-life, the transcriptional initiation levels should be the major determinants of the eventual transcript levels.<table-wrap id="Tab2"><label>Table 2</label><caption><p>
<bold>Statistics of the half-life associated with ChIP (&#x02212;) and ChIP (+) genes</bold>
</p></caption><table frame="hsides" rules="groups"><thead><tr valign="top"><th/><th>
<bold>Total</bold>
</th><th>
<bold>ChIP(&#x02212;) RNA(&#x02212;)</bold>
</th><th>
<bold>ChIP(&#x02212;) RNA(+)</bold>
</th><th>
<bold>ChIP(+) RNA(&#x02212;)</bold>
</th><th>
<bold>ChIP(+) RNA(+) (Total)</bold>
</th><th>
<bold>ChIP(+) RNA(+) (</bold>&#x000d7;<bold>2)</bold>
</th><th>
<bold>ChIP(+) RNA(+) (</bold>&#x000d7;<bold>1.1)</bold>
</th></tr></thead><tbody><tr valign="top"><td>
<bold>Number of genes with a RNA half-life</bold>
</td><td>
<bold>12,479</bold>
</td><td>
<bold>6,235</bold>
</td><td>
<bold>603</bold>
</td><td>
<bold>2,745</bold>
</td><td>
<bold>2,896</bold>
</td><td>
<bold>1,617</bold>
</td><td>
<bold>187</bold>
</td></tr><tr valign="top"><td>
<bold>Median half-life</bold>
</td><td>
<bold>nd</bold>
</td><td>
<bold>nd</bold>
</td><td>
<bold>13.2</bold>
</td><td>
<bold>6.0</bold>
</td><td>
<bold>11.6</bold>
</td><td>
<bold>11.0</bold>
</td><td>
<bold>10.9</bold>
</td></tr></tbody></table><table-wrap-foot><p>In Table&#x000a0;<xref rid="Tab2" ref-type="table">2</xref>, we only considered genes with compatible half-life measurements from BRIC-seq. ChIP(+): H3K4me3 intensities larger than 1&#x02009;&#x000d7;&#x02009;10<sup>4</sup> and a presence of polII peak , ChIP(&#x02212;): H3K4me3 intensities smaller than 1&#x02009;&#x000d7;&#x02009;10<sup>4</sup> and an absence of polII peak. RNA(+): RPKM value larger than 10, RNA(&#x02212;): RPKM value smaller than 10. For ChIP(+)/RNA(+) region; total: all genes, &#x000d7;2: genes within two-fold of the regression line, &#x000d7;1.1: genes within the 1.1-fold of the regression line. nd: not determined.</p></table-wrap-foot></table-wrap></p><p>For further analysis into the correlation, we also selected mRNA with &#x02018;short&#x02019; half-lives, specifically a total of 3,190 genes that had half-lives shorter than 4&#x000a0;hours. From the default half-life of 10.9&#x000a0;hours, we observed the standard deviation of the half-lives to be 3&#x000a0;hours, indicating that 4&#x000a0;hours was approximately the 95<sup>th</sup> percentile confidence level. These particular mRNAs are highlighted as red dots in Figure&#x000a0;<xref rid="Fig2" ref-type="fig">2</xref>e. We observed the enrichment of mRNAs with short half-lives in the ChIP+/RNA- fraction of the scatterplot (P-value&#x02009;=&#x02009;6.8&#x02009;&#x000d7;&#x02009;10<sup>&#x02212;16</sup>), in which gene expression values were lower than estimated by ChIP-seq data. These results suggest that control of mRNA stability is an important factor in determining the eventual mRNA levels for this population and indicate that the expression levels of these 866 genes may be controlled by mRNA stability in HeLa cells (see Additional file <xref rid="MOESM2" ref-type="media">2</xref>: Table S2). For validation, we used actinomycin D (ActD), a transcriptional inhibitor, and chased the RNA decay by RT-qPCR (Additional file <xref rid="MOESM1" ref-type="media">1</xref>: Figure S2). BAMBI and MED26 RNA half-lives (defined in BRIC analysis as ChIP(+)/RNA(&#x02212;)/short RNA half-life) determined by BRIC analysis were similar to those determined by ActD analysis. The transcripts of MMP2 and SLC25A23 (defined in BRIC analysis as ChIP(&#x02212;)/RNA(+)/long RNA half-life) were determined as stable RNAs in both BRIC and ActD chase analyses. In contrast, the RNA half-lives of ZNF691 and ZNF574 slightly varied between BRIC and ActD chase analyses. Thus, most RNA stabilities determined by BRIC analysis were confirmed by ActD chase analysis.</p><p>To analyze the categories of genes that receive regulation at either transcriptional initiation or RNA half-life levels, we ran GO enrichment analysis. Among the ChIP (+)/RNA (+) genes, GO terms associated with basic translation or transcriptional machineries were enriched (Table&#x000a0;<xref rid="Tab3" ref-type="table">3</xref>a). For the ChIP (&#x02212;)/RNA (+) genes, genes associated cytoplasm as a location were enriched (Table&#x000a0;<xref rid="Tab3" ref-type="table">3</xref>b), and for the ChIP (+)/RNA (&#x02212;) genes, GO terms associated with transcription factors were enriched, particularly among genes with a short half-life (t<sub>1/2</sub>&#x02009;&#x0003c;&#x02009;4&#x000a0;h) (Table&#x000a0;<xref rid="Tab3" ref-type="table">3</xref>c-d). These results suggest that different functional categories of genes are subjected to different modes of gene expression regulation.<table-wrap id="Tab3"><label>Table 3</label><caption><p>
<bold>List of GO enrichments for transcripts in different ChIP-seq and RNA-seq fractions</bold>
</p></caption><table frame="hsides" rules="groups"><tbody><tr valign="top"><td colspan="4">
<bold>A) ChIP (+)/RNA (+) GO enrichment</bold>
</td></tr><tr valign="top"><td>
<bold>GO:ID</bold>
</td><td>
<bold>GO: term</bold>
</td><td>
<bold>Number of genes</bold>
</td><td>
<bold>False-discovery rate</bold>
</td></tr><tr valign="top"><td>
<bold>GO: 0044822</bold>
</td><td>
<bold>poly (A) RNA binding</bold>
</td><td>
<bold>618</bold>
</td><td>
<bold>6.00e-261</bold>
</td></tr><tr valign="top"><td>
<bold>GO: 0006412</bold>
</td><td>
<bold>translation</bold>
</td><td>
<bold>293</bold>
</td><td>
<bold>3.86e-196</bold>
</td></tr><tr valign="top"><td>
<bold>GO: 0010467</bold>
</td><td>
<bold>gene expression</bold>
</td><td>
<bold>387</bold>
</td><td>
<bold>5.61e-162</bold>
</td></tr><tr valign="top"><td colspan="4">
<bold>B) ChIP (&#x02212;)/RNA (+) GO enrichment</bold>
</td></tr><tr valign="top"><td>
<bold>GO: ID</bold>
</td><td>
<bold>GO: term</bold>
</td><td>
<bold>Number of genes</bold>
</td><td>
<bold>False-discovery rate</bold>
</td></tr><tr valign="top"><td>
<bold>GO: 0005737</bold>
</td><td>
<bold>cytoplasm</bold>
</td><td>
<bold>138</bold>
</td><td>
<bold>2.26e-2</bold>
</td></tr><tr valign="top"><td>
<bold>GO: 0070062</bold>
</td><td>
<bold>extracellular vesicular exosome</bold>
</td><td>
<bold>74</bold>
</td><td>
<bold>2.61e-2</bold>
</td></tr><tr valign="top"><td>
<bold>GO: 0005635</bold>
</td><td>
<bold>nuclear envelope</bold>
</td><td>
<bold>15</bold>
</td><td>
<bold>2.81e-2</bold>
</td></tr><tr valign="top"><td colspan="4">
<bold>C) ChIP (+)/RNA (&#x02212;) GO enrichment</bold>
</td></tr><tr valign="top"><td>
<bold>GO: ID</bold>
</td><td>
<bold>GO: term</bold>
</td><td>
<bold>Number of genes</bold>
</td><td>
<bold>False-discovery rate</bold>
</td></tr><tr valign="top"><td>
<bold>GO: 0003677</bold>
</td><td>
<bold>DNA binding</bold>
</td><td>
<bold>378</bold>
</td><td>
<bold>2.96e-28</bold>
</td></tr><tr valign="top"><td>
<bold>GO: 0006355</bold>
</td><td>
<bold>regulation of transcription, DNA-templated</bold>
</td><td>
<bold>266</bold>
</td><td>
<bold>4.44e-17</bold>
</td></tr><tr valign="top"><td>
<bold>GO: 0006351</bold>
</td><td>
<bold>transcription, DNA-templated</bold>
</td><td>
<bold>361</bold>
</td><td>
<bold>8.60e-17</bold>
</td></tr><tr valign="top"><td colspan="4">
<bold>D) ChIP (+)/RNA (&#x02212;)/half-life&#x02009;&#x0003c;&#x02009;4&#x000a0;h GO enrichment</bold>
</td></tr><tr valign="top"><td>
<bold>GO: ID</bold>
</td><td>
<bold>GO: term</bold>
</td><td>
<bold>Number of genes</bold>
</td><td>
<bold>False-discovery rate</bold>
</td></tr><tr valign="top"><td>
<bold>GO: 0003677</bold>
</td><td>
<bold>DNA binding</bold>
</td><td>
<bold>216</bold>
</td><td>
<bold>5.19e-58</bold>
</td></tr><tr valign="top"><td>
<bold>GO: 0006351</bold>
</td><td>
<bold>transcription, DNA-templated</bold>
</td><td>
<bold>192</bold>
</td><td>
<bold>1.37e-37</bold>
</td></tr><tr valign="top"><td>
<bold>GO: 0006355</bold>
</td><td>
<bold>regulation of transcription, DNA-templated</bold>
</td><td>
<bold>147</bold>
</td><td>
<bold>5.13e-34</bold>
</td></tr></tbody></table></table-wrap></p></sec><sec id="Sec5"><title>Identification of UPF1, EXOSC5 and STAU1 as controlling factors for RNA stabilities</title><p>To evaluate the potential contribution of known RNA degradation factors to the control of global RNA stability, we chose three representative factors for analysis: UPF1, EXOSC5, and STAU1. It has been reported that UPF1 regulates 3&#x02013;20% of transcripts [<xref ref-type="bibr" rid="CR11">11</xref>-<xref ref-type="bibr" rid="CR13">13</xref>], highlighting the potential importance of UPF1 in regulating RNA degradation and abundance. EXOSC5 is an essential component of the exosome complex that is the major mRNA degradation machinery in mammalian cells. To analyze the alteration of global mRNA turnover by perturbation of representative factors, we examined EXOSC5. STAU1, which regulates around 1% of <italic>bona fide</italic> mRNAs [<xref ref-type="bibr" rid="CR18">18</xref>], is a typical RNA-binding protein involved in RNA degradation. We used data from BRIC assay in the cells depleted in UPF1 by siRNA (see <xref rid="Sec12" ref-type="sec">Methods</xref> for accession numbers). As observed in a previous study [<xref ref-type="bibr" rid="CR23">23</xref>], mRNA levels of the GADD45A gene, which is a known target of UPF1, were increased following UPF1 knockdown (Figure&#x000a0;<xref rid="Fig3" ref-type="fig">3</xref>a), with an increase in half-life (Figure&#x000a0;<xref rid="Fig3" ref-type="fig">3</xref>d). We then conducted similar experiments using EXOSC5 and STAU1 knockdown cells and prepared a similar RNA-seq and BRIC-seq dataset. We observed an increase of FAM120C mRNA levels (Figure&#x000a0;<xref rid="Fig3" ref-type="fig">3</xref>b) and an increase in half-life (Figure&#x000a0;<xref rid="Fig3" ref-type="fig">3</xref>e) in EXOSC5 knockdown cells. In STAU1 knockdown cells, the mRNA levels of CDKN2B were increased (Figure&#x000a0;<xref rid="Fig3" ref-type="fig">3</xref>c), with increased half-lives (Figure&#x000a0;<xref rid="Fig3" ref-type="fig">3</xref>f).<fig id="Fig3"><label>Figure 3</label><caption><p>
<bold>Identification of UPF1, EXOSC5 and STAU1 as factors controlling RNA half-lives. (a&#x02013;c)</bold> ChIP-seq and RNA-seq for the GADD45A <bold>(a)</bold>, FAM120C <bold>(d)</bold> and CDKN2B <bold>(c)</bold> genes, which showed significant changes in RNA half-lives in UPF1, EXOSC5 and STAU1 knocked-down cells, respectively. Upper two panels in <bold>(a&#x02013;c)</bold>: ChIP-seq data for H3K4me3 and pol II. Lower two panels in <bold>(a&#x02013;c)</bold>: RNA-seq data for control cells and the respective knockdown cells. <bold>(d&#x02013;f)</bold> BRIC-seq normalized graph for GADD45A <bold>(d)</bold>, FAM120C <bold>(e)</bold> and CDKN2B <bold>(f)</bold> genes in control cells or cells knocked-down for UPF1 <bold>(d)</bold>, EXOSC5 <bold>(e)</bold>, and STAU1 <bold>(f). (g)</bold> Scatterplot representing the ChIP-seq peak signal intensities of H3K4me3 on the y-axis and gene expression values on the x-axis with putative UPF1-controlled genes, EXOSC5-controlled and STAU1-controlled genes in blue, green and red dots respectively.</p></caption><graphic xlink:href="12864_2015_1358_Fig3_HTML" id="MO3"/></fig></p><p>We next looked for genes that may be regulated by these factors, and identified 266, 219 and 39 genes where the mRNA half-lives were extended by more than two-fold (in UPF1 and EXOSC5 knockdown cells) or 1.5-fold (in STAU1 knockdown cells) and showed mRNA expression increase by two-fold (in UPF1 and EXOSC5 knockdown cells) or 1.5-fold (in STAU1 knockdown cells) in UPF1, EXOSC5 and STAU1 knockdown cells, respectively. As shown in Figures&#x000a0;<xref rid="Fig3" ref-type="fig">3</xref>a, <xref rid="Fig3" ref-type="fig">3</xref>b and <xref rid="Fig3" ref-type="fig">3</xref>c, we noticed that the transcripts that were not observed in the control knockdown cells appeared in the knocked-down cells in many cases. We examined the distribution of the dots of these genes, whose transcripts were stabilized and increase in corresponding knockdown cells, in Figure&#x000a0;<xref rid="Fig1" ref-type="fig">1</xref>b and found that they are enriched in the upper-left corner of the plot. In total, we identified 23, 40 and 4 genes (Additional file <xref rid="MOESM2" ref-type="media">2</xref>: Table S3) whose mRNA half-lives are potentially controlled by UPF1, EXOSC5 and STAU1 respectively, consisting of 3, 5, and 0.5% of the total of 1,279 genes (ChIP (+), RNA (&#x02212;), half-life&#x02009;&#x0003c;&#x02009;4&#x000a0;h) in this area. We also examined the overlap between the genes controlled by UPF1 and EXOSC5 and found little overlap (Table&#x000a0;<xref rid="Tab4" ref-type="table">4</xref>). Although we could identify UPF1, EXOSC5 and STAU1 as control factors only for a limited population (8% of ChIP+/RNA-/t1/2&#x02009;&#x0003c;&#x02009;4&#x000a0;h genes) by this approach. These observations are only the first step in identifying the role of RNA decay factors in determination of RNA abundance through RNA degradation, and further systematic analyses may facilitate identification of the complex regulatory mechanisms of mRNA stabilities.<table-wrap id="Tab4"><label>Table 4</label><caption><p>
<bold>Summary statistics used for the analysis of RefSeq transcripts</bold>
</p></caption><table frame="hsides" rules="groups"><thead><tr valign="top"><th>
<bold>Conditions (Refseq)</bold>
</th><th>
<bold>Number of genes</bold>
</th></tr></thead><tbody><tr valign="top"><td>
<bold>Active transcription (supported by H3K4me3 and pol II peaks) and half-life measured</bold>
</td><td>
<bold>6,105</bold>
</td></tr><tr valign="top"><td>
<bold>With short half-life (~4&#x000a0;h)</bold>
</td><td>
<bold>1,291</bold>
</td></tr><tr valign="top"><td>
<bold>with low expression (10rpkm and below) and high H3K4me3 (1</bold>&#x02009;&#x000d7;&#x02009;<bold>10</bold>
<sup><bold>4</bold></sup>
<bold>and above)</bold>
</td><td>
<bold>866</bold>
</td></tr><tr valign="top"><td>
<bold>and UPF1 target</bold>
</td><td>
<bold>26 (3.0%)</bold>
</td></tr><tr valign="top"><td>
<bold>or EXOSC5 target</bold>
</td><td>
<bold>40 (4.6%)</bold>
</td></tr><tr valign="top"><td>
<bold>or STAU1 target</bold>
</td><td>
<bold>4 (0.46%)</bold>
</td></tr></tbody></table></table-wrap></p></sec><sec id="Sec6"><title>Computational modeling of the effect of mRNA half-lives on eventual mRNA levels</title><p>We predicted the RNA abundance by normalizing the half-life to be 10.9&#x000a0;hours, the estimated default half-life (from Figure&#x000a0;<xref rid="Fig2" ref-type="fig">2</xref>c), and obtained the least squares regression line between the predicted RNA levels and H3K4me3 intensities. We made a threshold of&#x02009;&#x000d7;&#x02009;1.1 and&#x02009;&#x000d7;&#x02009;2, above and below the least-square regression line to define genes where the H3K4me3 intensities and RNA abundance correlate. We found that out of 9,407 genes that were available from BRIC-seq dataset, we found 2,593 and 242 genes that resided within&#x02009;&#x000d7;&#x02009;2 and&#x02009;&#x000d7;&#x02009;1.1 of the regression line, respectively (Figure&#x000a0;<xref rid="Fig4" ref-type="fig">4</xref>a and Table&#x000a0;<xref rid="Tab5" ref-type="table">5</xref>). We checked the original gene expression of those genes prior to the simulation, and checked whether their measured RNA abundance correlates with H3K4me3 intensities. We found out of 2,593 and 242 genes that resided within&#x02009;&#x000d7;&#x02009;2 and&#x02009;&#x000d7;&#x02009;1.1 of the regression line from predicted gene expression, we found 1,540 and 229 genes where measured to be outside of the threshold, respectively. It means that the RNA stability of those genes contributed to the RNA abundance. Taken together, these results collectively support our claim that RNA degradation significantly contributes in determining the eventual expression levels (Figure&#x000a0;<xref rid="Fig4" ref-type="fig">4</xref>a).<fig id="Fig4"><label>Figure 4</label><caption><p>
<bold>Computational simulations of the RNA half-lives as a determinant for transcript level. (a)</bold> Computational simulation into the effect of RNA half-life on RNA abundance. Each gene was simulated to have a half-life of 10.9&#x000a0;hours, potential default half-life, and the predicted gene expression was plotted against the H3K4me3 intensities, along with the measured gene expression. The dotted line indicates the least-squares regression line between the predicted gene expression and H3K4me3 intensities. <bold>(b-d)</bold> Result of the computational simulation of the predicted RNA expression when each RNA abundance was predicted from RNA half-life when <bold>(b)</bold>UPF1, <bold>(c)</bold> EXOSC5 and <bold>(d)</bold> STAU1 were knocked-down, in comparison to each control knock-down conditions. The predicted gene-expression of the decay factor knock-down and the measured gene-expression of control knock-down were plotted against H3K4me3 intensities. The dotted line indicates the least-squares regression line between the predicted gene expression and H3K4me3 intensities.</p></caption><graphic xlink:href="12864_2015_1358_Fig4_HTML" id="MO4"/></fig><table-wrap id="Tab5"><label>Table 5</label><caption><p>
<bold>Summary statistics of computational simulation</bold>
</p></caption><table frame="hsides" rules="groups"><thead><tr valign="top"><th>
<bold>Condition</bold>
</th><th>
<bold>t1/2=10.9 hours</bold>
</th><th>
<bold>siUPF1</bold>
</th><th>
<bold>siEXOSC5</bold>
</th><th>
<bold>siSTAU1</bold>
</th></tr></thead><tbody><tr valign="top"><td>Total</td><td>9407</td><td>9387</td><td>9852</td><td>9334</td></tr><tr valign="top"><td>x2 predicted under condition (x)</td><td>2593</td><td>5408</td><td>2484</td><td>3753</td></tr><tr valign="top"><td>of which was not within x2 in &#x0201c;measured&#x0201d;</td><td>1540</td><td>815</td><td>680</td><td>294</td></tr><tr valign="top"><td>x1.1 under condition (x)</td><td>242</td><td>555</td><td>245</td><td>651</td></tr><tr valign="top"><td>of which was not within x1.1 measured</td><td>229</td><td>439</td><td>200</td><td>486</td></tr></tbody></table></table-wrap></p><p>Additionally, we conducted ChIP-seq on H3K27ac, H3K27me3, H3K36me3 to build a linear model as described by Wan<italic>g</italic>, C., <italic>et. al.</italic> [<xref ref-type="bibr" rid="CR7">7</xref>]<italic>,</italic>. We built one linear model incorporating H3K4me3, H3K27Ac, H3K27me3 and H3K36me3 intensities with half-life as an extra variable, and one without the half-life, to explain the RNA abundance. We found that fitting increased from 0.41 to 0.58 in R-value, which confirmed the previous finding by Wang. <italic>et. al.,</italic>[<xref ref-type="bibr" rid="CR7">7</xref>]<italic>.</italic></p><p>We examined whether the changes in the RNA half-lives from knockdown of UPF1, EXOSC5 or STAU1 could explain the changes in the eventual transcript levels. For this analysis, we conducted a computational simulation. As shown in Additional file <xref rid="MOESM1" ref-type="media">1</xref>: Figure S3, we found that the described theoretical model can predict the changes of eventual RNA levels with Pearson&#x02019;s correlation co-efficiency of 0.8, 0.8 and 0.7, respectively. Overall, we demonstrate that the simple computational model could reasonably explain the changes of eventual mRNA levels, thus supporting our idea that the major determinant of the eventual RNA levels in these cases is at the level of RNA stability. We further simulated the RNA abundance, from the changes in RNA half-life, in relation to the ChIP-seq signal levels and we found 439, 486, and 200 genes that were within&#x02009;&#x000d7;&#x02009;1.1 of the regression line that lied outside of the threshold prior to simulation, for UPF1, EXOSC5, and STAU1, respectively (Figures&#x000a0;<xref rid="Fig4" ref-type="fig">4</xref>b-d).</p></sec><sec id="Sec7"><title>Possible feedback between mRNA turnover and transcriptional initiation</title><p>To analyze the possible feedback mechanisms between mRNA turnover and transcription initiation, we used the genes in which both mRNA half-lives and eventual transcript levels were increased more than two fold in knockdown cells. In 975 and 6,309 genes in UPF1 and EXOSC5 knockdown cells, respectively, there were no significant changes in eventual transcript levels (within two fold) observed despite remarkable changes to their RNA half-lives (more than two fold). We speculated that there might be a possible feedback between mRNA turnover and transcriptional rate. If mRNAs for a particular group of transcriptional repression factors are included in the UPF1/EXOSC5 targets and their stabilized mRNAs result in increased protein levels of such transcriptional repression factors, thereby enhancing the repression activities on their target genes, it would explain unchanged balance of eventual transcript levels for these genes. We examined whether any transcription factor binding sites were enriched in the upstream regions of the 975 and 6,309 genes. In the case of UPF1, we detected significant enrichment of the consensus binding site for HIC1, which is a transcription factor belonging to the zinc finger family. We validated the changes of its expression level and half-lives in control and UPF1 knockdown cells, and confirmed HIC1 as a UPF1 target (Additional file <xref rid="MOESM1" ref-type="media">1</xref>: Figure S3a). We were unable to further validate direct binding of HIF1 to target genes, since no effective antibodies are available. Also, it is possible that HIC1 may not be the only candidate, which may contribute to the feedback regulation. Many zinc finger family transcription factors share consensus binding sequences. The list of putative zinc finger family transcription factors that have significant homology to HIC1 in their DNA binding domains with extended half-lives (e.g. ZNF783 shown in Additional file <xref rid="MOESM1" ref-type="media">1</xref>: Figure S3b) and increased eventual transcript levels upon UPF1 knockdown are shown in Additional file <xref rid="MOESM2" ref-type="media">2</xref>: Table S3. These factors may collectively enable elaborate regulation of gene expression.</p></sec><sec id="Sec8"><title>Identification of candidate genes controlled through RNA stability in other cell types</title><p>To further extend our idea that controls at the level of mRNA decay contribute to determining eventual mRNA expression levels in other cell types, we analyzed the published ENCODE data [<xref ref-type="bibr" rid="CR25">25</xref>] and DBTSS [<xref ref-type="bibr" rid="CR26">26</xref>], which included ChIP-seq data of H3K4me3 and pol II and RNA-seq in a wide variety of cell types. In addition, the RNA-seq data of subcellular fractionated mRNAs were included in the dataset. We selected eight cell types for which all these datasets were available (details in Additional file <xref rid="MOESM1" ref-type="media">1</xref>: Figure S4a). We retrieved and analyzed the ChIP-seq data and RNA-seq data as performed with HeLa cells. First, as shown in Additional file <xref rid="MOESM1" ref-type="media">1</xref>: Figure S6, we observed weak correlations between ChIP-seq intensities of H3K4me3 and gene expression values as reported in HeLa cells.</p><p>Since there were no BRIC-seq data in the ENCODE dataset, we could not directly analyze the genes with short mRNA half-lives. Nevertheless, we could select genes for which ChIP-seq tags of H3K4me3 and pol II were associated, thus indicated as actively transcribed in the cell line, although their gene expression levels were not at the expected levels. In the ENCODE dataset, we also considered a positive signal of H3K36me3, which is a chromatin mark for transcriptional elongation, to further assure active transcription [<xref ref-type="bibr" rid="CR27">27</xref>]. We identified an average of 338 candidate genes with active transcription and low RNA abundance in each cell type (Figure&#x000a0;<xref rid="Fig5" ref-type="fig">5</xref>a), which should be regulated at the level of mRNA decay. We examined and identified GO terms that were significantly enriched, depending on cell types, and the top enriched terms were predominantly associated with DNA binding (Figure&#x000a0;<xref rid="Fig5" ref-type="fig">5</xref>b). We also analyzed whether there are any cases for a particular gene to be selected as such a candidate in a cell type-preferred manner. We found that 2,705 potential controls at the level of RNA half-life were observed in a single cell type (Additional file <xref rid="MOESM2" ref-type="media">2</xref>: Table S5, Additional file <xref rid="MOESM1" ref-type="media">1</xref>: Figure S6). We also examined if there was possible feedback between controls of RNA half-lives and transcription initiations. We found that several transcription factor binding consensus sequences of the ETS family and AREBP family genes are enriched in the promoters of the genes inferred to be regulated at the level of RNA stability in Gm12878 cells and HepG2 cells, respectively. In addition, we identified HIC1 binding consensus sequences in the promoters of the genes inferred to be regulated at the level of RNA stability in human H1 embryonic stem cells. The feedback regulations may be common in various cell types with distinct responsive transcription factors depending on cell type (Figures&#x000a0;<xref rid="Fig5" ref-type="fig">5</xref>c, d). We further analyzed the subcellular localizations of the mRNAs of these genes using the corresponding ENCODE data. We found significantly enriched mRNAs in the cytoplasm only in the embryonic stem cells (H1-hES) (<italic>p</italic>-value 6.5 x 10<sup>&#x02212;18</sup>) (Figure&#x000a0;<xref rid="Fig5" ref-type="fig">5</xref>e), suggesting there may be a characteristic regulatory mechanism for controlling RNA stability in the cytoplasm of ES cells. On the whole, these data should provide an important complement to the ENCODE annotations, which aim to generate a complete catalogue of genetic elements explaining gene expression regulation.<fig id="Fig5"><label>Figure 5</label><caption><p>
<bold>Screening of candidate genes that may be controlled at the level of RNA degradation from the ENCODE dataset. (a)</bold> Number of candidate genes screened from the indicated cell types based on the ENCODE data. <bold>(b)</bold> Gene ontology (GO) enrichment of genes in the ChIP (+) / RNA (&#x02212;) regions in the indicated cell types based on the ENCODE data. ChIP-seq signal intensities were comparable between different cell types, although RNA-seq-based gene expression values were remarkably different. The GO term enrichment with the lowest P-value for each cell line is shown. <bold>(c, d)</bold> Enriched consensus transcription factor binding sites for genes in the ChIP (+) / RNA (&#x02212;) region for ENCODE dataset. <bold>(c)</bold> Graphical representation of the enriched consensus binding sites in the promoter regions of the genes in ChIP (+) / RNA (&#x02212;) region for ENCODE dataset. <bold>(d)</bold> The list of cell lines with consensus binding site enrichment from the TRANSFAC database. <bold>(e)</bold> The nuclear/cytoplasmic gene expression values for the genes where RNA half-life may be the contributor to the RNA levels and all other genes in H1 human embryonic stem cells (hesc). Statistical significance of the difference is indicated under the x-axis.</p></caption><graphic xlink:href="12864_2015_1358_Fig5_HTML" id="MO5"/></fig></p></sec><sec id="Sec9"><title>Distinct controls of the RNA stabilities of mRNAs and non-coding RNAs</title><p>To examine whether the regulations at the level of RNA half-lives are observed in lincRNAs, we conducted a similar analysis for lincRNAs in HeLa cells, as shown in Figures&#x000a0;<xref rid="Fig1" ref-type="fig">1</xref> and <xref rid="Fig2" ref-type="fig">2</xref>. We tentatively defined the dataset of lincRNA as that of lincDB [<xref ref-type="bibr" rid="CR28">28</xref>]. As shown in Figures&#x000a0;<xref rid="Fig6" ref-type="fig">6</xref>a and <xref rid="Fig6" ref-type="fig">6</xref>b, we associated the ChIP-seq peak intensities and gene expression values. We unexpectedly observed distinct patterns from those of mRNAs. Namely, among 141 lincRNAs in HeLa cells, 103 lincRNAs had &#x0201c;short (&#x0003c;4&#x000a0;h)&#x0201d; RNA half-lives. Of these, 84 (82%) resided in the upper-left corner of the plot, suggesting that most of the lincRNAs are controlled at the post-transcriptional level. Because there are reports on the possible involvement of NMD in regulating non-coding RNA [<xref ref-type="bibr" rid="CR29">29</xref>,<xref ref-type="bibr" rid="CR30">30</xref>], we examined the possible involvement of UPF1 in the regulation of lincRNAs. Interestingly, none of the 84 lincRNAs were detected as potential UPF1-controlled transcripts. In this data set, UPF1 may have only limited contribution. By contrast, we found 26 (31%) of the lincRNAs (Table&#x000a0;<xref rid="Tab6" ref-type="table">6</xref>, Additional file <xref rid="MOESM2" ref-type="media">2</xref>: Table S3) were regulated by EXOSC5.<fig id="Fig6"><label>Figure 6</label><caption><p>
<bold>Contribution of the RNA half-lives to transcriptional regulations of lincRNAs. (a, b)</bold> Scatterplot showing the relationships between H3K4me3 intensities and gene expression for all lincRNA <bold>(a)</bold> and those that were BRIC-seq compatible (red dots: t<sub>1/2</sub>&#x02009;&#x0003c;&#x02009;4&#x000a0;h) <bold>(b). (c, d)</bold> Examples of lincRNAs regulated by UPF1 <bold>(c)</bold> and EXOSC5 <bold>(d)</bold>. Upper panels are H3K4me3 and pol II peaks, and lower panels are RNA-seq measurements for the control and indicated knockdown. UPF1 <bold>(e)</bold> and EXOSC5 <bold>(f)</bold> show the normalized decay curve from the BRIC-seq measurements for these examples. Red lines are siUPF1 <bold>(e, g)</bold> or siEXOSC5 <bold>(f, h)</bold> data, respectively and blue lines are si_control data. Enhancer RNAs (eRNAs) regulated by UPF1 <bold>(g)</bold> or EXOSC5 <bold>(h)</bold>. The label shows the genomic coordinates of these eRNAs (in hg19 build). These show normalized decay curves for the BRIC-seq measurements for these examples as above.</p></caption><graphic xlink:href="12864_2015_1358_Fig6_HTML" id="MO6"/></fig><table-wrap id="Tab6"><label>Table 6</label><caption><p>
<bold>Summary statistics used for the analysis of lincRNAs</bold>
</p></caption><table frame="hsides" rules="groups"><thead><tr valign="top"><th>
<bold>Conditions (lincDB)</bold>
</th><th>
<bold>Number of genes</bold>
</th></tr></thead><tbody><tr valign="top"><td>
<bold>Active transcription and half-life measured</bold>
</td><td>
<bold>141</bold>
</td></tr><tr valign="top"><td>
<bold>With short half-life (~4&#x000a0;h)</bold>
</td><td>
<bold>103</bold>
</td></tr><tr valign="top"><td>
<bold>with low expression (10RPKM and below) and high H3K4me3 (1E4 and above)</bold>
</td><td>
<bold>84</bold>
</td></tr><tr valign="top"><td>
<bold>and UPF1 target</bold>
</td><td>
<bold>0</bold>
</td></tr><tr valign="top"><td>
<bold>or EXOSC5 target</bold>
</td><td>
<bold>26 (31%)</bold>
</td></tr></tbody></table></table-wrap></p><p>We next examined whether enhancer RNAs (eRNA), which facilitate the functions of the enhancers, are also regulated at the level of RNA degradation. We again used the ENCODE data from HeLa cells. We retrieved the ChIP-seq data of H3K4me and H3K27Ac, which are representative chromatin marks of active enhancers. Among 49,903 genomic regions having &#x0201c;peaks&#x0201d; of both H3K4me1 and H3K27Ac, we identified 77 cases in which there were RNAs in the overlapping regions (shown in Figure&#x000a0;<xref rid="Fig6" ref-type="fig">6</xref>g), 1.5&#x000a0;kb away from any RefSeq gene body and their RNA half-lives were extended by UPF1 knockdown by more than two fold in BRIC-seq assay. Similarly, we identified 358 cases in which half-lives of RNAs in overlapping regions were examined (shown in Figure&#x000a0;<xref rid="Fig6" ref-type="fig">6</xref>h, listed in Additional file <xref rid="MOESM2" ref-type="media">2</xref>: Table S6) and in which transcripts showed extended RNA half-lives of more than two-fold in EXOSC5 knockdown cells. Although further detailed experimental validations are necessary, these results may indicate that controls mediated by RNA stability are used in determining the transcript levels of non-coding RNAs.</p></sec></sec><sec id="Sec10" sec-type="discussion"><title>Discussion</title><p>Here, we have described a genome-wide correlation among the signal intensities of ChIP-seq, gene expression values measured by RNA half-lives measured by BRIC-seq. We identified that regulation at the level of RNA degradation plays an important role in determining eventual RNA levels. We demonstrated that this control may exhibit a particularly large effect in cases in which the ChIP-seq data and RNA-seq data are inconsistent. Indeed, in this study, we estimated that the abundance of 866 mRNAs is regulated by RNA degradation in HeLa cells. Furthermore, we applied similar approaches to analyze the public ENCODE data and identified a total of 2,705 candidate genes whose gene expression levels are likely to be controlled at the level of RNA stability. We also found that these controls appeared to vary among cell types. To our knowledge, this is the first report that describes the integration of the ChIP-seq, RNA-seq and RNA half-life data in identifying genes that may receive post-transcriptional gene expression regulation. In GO analyses, there are some limitations because GO terms may be loosely defined for a particular gene. However, we first selected GO terms with statistical significance (FDR&#x02009;&#x0003c;&#x02009;0.05), and we only used GO term enrichment with more than 10 genes in a set to ensure minimum false positives, which will ensure that the GO terms described are representative of the biological phenomenon. We then found enrichment of transcription factors in transcripts with discrepancies between the ChIP-seq and RNA-seq with short half-lives, and in particular, negative regulatory factors. In a recent study, Haimovich <italic>et al.</italic> [<xref ref-type="bibr" rid="CR31">31</xref>] indicated that some RNA degradation factors play a role in transcription, implicating a feedback loop for gene expression. Our data suggest another mechanism by which this occurs, through a faster degradation rate of mRNAs encoding transcription factors, particularly for those that negatively regulate gene expression, thus affecting the eventual RNA levels. Previous studies conducted by Wang <italic>et. al.</italic>, demonstrated that RNA stability could in inferred from the residual errors in modeling the RNA abundance from ChIP-seq data and they validated their claims from a half-life data; however, they used RNA stability data from a different cell-line [<xref ref-type="bibr" rid="CR7">7</xref>], and they could not accurately predict the eventual RNA abundance from the RNA stability. Herein, by analyzing RNA stability data from the same cell-line as RNA-seq data, we were able to estimate the contribution of the RNA stability to the RNA abundance. In addition we were able to estimate the RNA stability contributions on the RNA abundance upon UPF1, STAU1 and EXOSC5 knockdown.</p><p>Although we did not demonstrate how the RNA half-lives are controlled in the current study and we identified UPF1, EXOSC5 and STAU1 as control factors in some cases, they could explain at most 8% of the total mRNA population. Even for the cases of candidate UPF1, EXOSC5 or STAU1-controlled genes, it is possible that they may not be direct targets of these factors and that we may have picked up secondary or later effects as a consequence of UPF1, EXOSC5 or STAU1 knockdowns. Another obvious drawback of our approach is that mRNA half-lives were not directly measured by BRIC-seq for the ENCODE dataset. Therefore, it is possible that they may be mediated by other regulatory mechanisms, rather than at the level of RNA half-lives, such as RNA halting and abortive transcriptions. To minimize these possibilities, we selected the cases in which H3K36me3, a marker of transcriptional elongation, should be significant in the transcript regions.</p><p>In spite of several drawbacks, we believe that genome-wide features of correlation among ChIP-seq, RNA-seq and BRIC-seq should give an important starting point to further explore posttranscriptional regulatory mechanisms, for which only limited knowledge has been accumulated. Indeed, recent papers have begun to reveal many human diseases that are caused by malfunctions of RNA decay pathway. In particular, it has been made gradually clear that most immune-response mRNAs are destabilized when they are not required via their cis-regulatory elements in the 3&#x02032; UTR. It is proposed that such RNA-decay mechanisms collectively enable rapid up-/downregulation of gene expression in response to environmental changes. The AU-rich element (ARE) is one of such elements widely found in the 3&#x02032; UTR of mRNA of immune-related genes. Mice lacking ARE in the TNF-alpha mRNA showed joint and gut-associated immunopathologies [<xref ref-type="bibr" rid="CR32">32</xref>]. The trans-acting factor regulatory RNase 1 (Regnase-1, also known as Zc3h12a or MCPIP1), which is induced by Toll-like receptor (TLR) ligands, interleukin (IL)-1&#x003b2; and MCP-1, is involved in the destabilization of mRNAs including Il6 mRNA. Regnase-1-deficient mice develop severe autoimmune disease because of excess production of cytokines [<xref ref-type="bibr" rid="CR33">33</xref>], highlighting the importance of RNA degradation-mediated gene regulation. In addition to immunological disorders, there are a growing number of cases with impaired RNA decay regulation that cause disease, and they sometimes reveal unexpected connections between otherwise completely unrelated diseases. Perlman syndrome, an autosomal recessively inherited congenital overgrowth syndrome associated with high neonatal mortality, is an obvious example. The survivors of this disease have a high risk of Wilms tumor. Recently, it was reported that the responsible gene of this disease is the exoribonuclease DIS3L2, a homologue of exosome component DIS3 [<xref ref-type="bibr" rid="CR34">34</xref>,<xref ref-type="bibr" rid="CR35">35</xref>]. Moreover, DIS3L2 is mutated in approximately 3&#x02013;6% of carcinomas [<xref ref-type="bibr" rid="CR35">35</xref>].</p><p>In this study, we have also analyzed the stabilities of non-coding RNAs (lincRNAs and eRNAs) and mRNAs. We and another study reported that stability of non-coding RNAs is also tightly regulated, suggesting that the instability contributes to the dynamic nature of lincRNAs [<xref ref-type="bibr" rid="CR22">22</xref>,<xref ref-type="bibr" rid="CR36">36</xref>]. Indeed, the stability of noncoding RNAs has an impact on their biological function [<xref ref-type="bibr" rid="CR29">29</xref>,<xref ref-type="bibr" rid="CR37">37</xref>-<xref ref-type="bibr" rid="CR39">39</xref>], although the exploration into its relevance in human disease has just begun. Further enrichment of our knowledge on the control mechanisms on RNA stability both for mRNAs and non-coding RNAs will shed new light on putative disease-associated genetic or somatic mutations.</p></sec><sec id="Sec11" sec-type="conclusions"><title>Conclusions</title><p>By integrative analysis of ChIP-seq, RNA-seq and our BRIC-seq, we showed that RNA half-life may serve as an important post-transcriptional determinant of gene expression. We suggest that UPF1, EXOSC5 and STAU1 may play active roles in such controls. In addition, we propose the linkage between transcription and RNA decay through regulated degradation of mRNAs encoding transcription factors to maintain the steady state level of RNA abundance.</p></sec><sec id="Sec12" sec-type="methods"><title>Methods</title><p>RNA-seq and BRIC-seq data for UPF1 were obtained from a previous study [<xref ref-type="bibr" rid="CR23">23</xref>]. The accession numbers for the sequencing data are [DDBJ:DRA000591] and [DDBJ:DRA001215]. &#x02018;Basal&#x02019; RNA-seq libraries, EXOSC5 and STAU1 knockdown RNA-seq libraries were sequenced according to the standard protocol from mRNA-seq Sample Preparation (Illumina, San Diego, CA). The outline of the experimental procedures is as follows.</p><sec id="Sec13"><title>Cell culture and siRNA transfection</title><p>HeLa cells were grown in Dulbecco&#x02019;s Modified Eagle&#x02019;s Medium (DMEM) supplemented with 10% fetal bovine serum and antibiotics at 37&#x000b0;C at 5% CO<sub>2</sub> in a humidified incubator. siRNAs were transfected (final concentration 10 nM) using Lipofectamine RNAiMAX (Invitrogen, Carlsbad, CA), according to the instructions from the manufacturer. Cells were harvested 72&#x000a0;h after the transfection. The knockdown efficiencies were determined by RT-qPCR (see Additional file <xref rid="MOESM1" ref-type="media">1</xref>: Figure S7). The sequences of siRNAs are provided in Additional file <xref rid="MOESM1" ref-type="media">1</xref>: Figure S8.</p></sec><sec id="Sec14"><title>RT-qPCR</title><p>The isolated RNAs were reverse-transcribed into cDNA using the PrimeScript RT Master Mix (TaKaRa, Otsu, Japan). The target cDNAs were amplified by SYBR Premix Ex Taq II (TaKaRa) according to the manufacturer&#x02019;s instructions, using the primer sets listed in Additional file <xref rid="MOESM1" ref-type="media">1</xref>: Figure S8. GAPDH was used for normalization. Quantitative real-time reverse transcription PCR analysis was performed using a Thermal Cycler Dice Real Time System (TaKaRa).</p></sec><sec id="Sec15"><title>RNA-seq</title><p>Approximately 1&#x000a0;&#x003bc;g RNA was used to sequence an RNA-seq library using the mRNA-seq Sample Preparation Kit (Illumina) according to the manufacturer&#x02019;s protocol. Thirty-six base pair single-end-read RNA-seq were generated from the Illumina GA sequencer, according to the standard protocol. The fluorescent images were processed to nucleotide sequences using the analysis Pipeline software supplied by Illumina. The reads mapping to the ribosomal RNA genes were removed. The filtered sequences were mapped to the reference human genome (hg19) using Tophat (version 2.0.8) [<xref ref-type="bibr" rid="CR40">40</xref>], only allowing the reads to be processed if the reads were compatible with the gene annotation files from the RefSeq [<xref ref-type="bibr" rid="CR41">41</xref>] and lincRNA [<xref ref-type="bibr" rid="CR28">28</xref>] databases (downloaded on 2<sup>nd</sup> July 2013). For the enhancer RNA (eRNA) analysis, Tophat (version 2.0.8) was used but without specifying the annotation and allowing novel splice-junctions to occur. Mapped reads were quantified using Cufflinks (version 2.1.1) [<xref ref-type="bibr" rid="CR42">42</xref>]. The transcript with the highest expression was used as a representative transcript for the given gene and the RPKM values of all transcripts in the same genes were added together to give RPKM values for the gene.</p></sec><sec id="Sec16"><title>BRIC-seq</title><p>BRIC was performed as previously described [<xref ref-type="bibr" rid="CR21">21</xref>,<xref ref-type="bibr" rid="CR22">22</xref>]. In brief, cells were incubated at 37&#x000b0;C in the presence of 150&#x000a0;&#x003bc;M 5&#x02032;-bromo-uridine (BrU) (Wako, Osaka, Japan) for 24&#x000a0;h in a humidified incubator with 5% CO<sub>2</sub>. After replacing BrU-containing medium with BrU-free medium, cells were harvested at indicated time points. Total RNA was isolated using RNAiso Plus (TaKaRa). Twelve micrograms of BrU-labeled total RNA were denatured by heating at 80&#x000b0;C for 1&#x000a0;min and then added to anti-BrdU mAb-conjugated beads containing 2&#x000a0;&#x003bc;g of anti-BrdU mAb (clone 2B1, MBL). The mixture was incubated at room temperature for 1&#x000a0;h with rotation. Beads were washed four times with 0.1% BSA in PBS. ISOGEN LS (Nippon Gene, Tokyo, Japan) was added, followed by RNA isolation, according to the manufacturer&#x02019;s instructions. The isolated RNA was used for deep sequencing using the mRNA-seq Sample Preparation Kit using the same protocol as RNA-seq. Data processing was conducted by the identical procedures as the RNA-seq method above. For BRIC-seq data without transfection, we used 13 time points to calculate half-life: 0&#x000a0;min, 15&#x000a0;min, 30&#x000a0;min, 45&#x000a0;min, 1&#x000a0;h, 1.5&#x000a0;h, 2&#x000a0;h, 3&#x000a0;h, 4&#x000a0;h, 6&#x000a0;h, 8&#x000a0;h, 10&#x000a0;h and 12&#x000a0;h. For UPF1 knockdown data, four time-points were taken: 0&#x000a0;min, 4&#x000a0;h, 8&#x000a0;h and 12&#x000a0;h. For STAU1 knockdown data, 11 time-points were taken: 0&#x000a0;min, 15&#x000a0;min, 45&#x000a0;min, 75&#x000a0;min, 105&#x000a0;min, 165&#x000a0;min, 225&#x000a0;min, 345&#x000a0;min, 465&#x000a0;min, 585&#x000a0;min and 705&#x000a0;min. For EXOSC5 knockdown data, five time-points were taken: 0&#x000a0;min, 4&#x000a0;h, 8&#x000a0;h, 12&#x000a0;h and 24&#x000a0;h. Calculation of RNA half-lives were conducted as previously described [<xref ref-type="bibr" rid="CR21">21</xref>].</p></sec><sec id="Sec17"><title>ActD chase analysis</title><p>Total RNA was isolated from HeLa cells at the indicated time points after addition of ActD (2&#x000a0;&#x003bc;g/ml), followed by RT-qPCR analysis to determine the degradation kinetics of each mRNA.</p></sec><sec id="Sec18"><title>ChIP-seq</title><p>ChIP-seq was conducted as previously described [<xref ref-type="bibr" rid="CR43">43</xref>-<xref ref-type="bibr" rid="CR45">45</xref>]. The following antibodies were used in each experiment: anti-histone H3K4me3 antibody (Abcam, Cambridge, UK, ab1012) ,anti-RNA polymerase II (Abcam ab817), monoclonal anti-H3K27me3 antibody (Abcam, ab6002), polyclonal anti-H3K27Ac antibody (Abcam, ab4729), polyclonal anti-H3K36me3 antibody (Abcam, ab9050) For ChIP-seq, Illumina&#x02019;s Eland was used to map the 36&#x000a0;bp reads to the reference human genome (hg19). Peaks were called by MACS 1.4.1 [<xref ref-type="bibr" rid="CR24">24</xref>] at default settings.</p></sec><sec id="Sec19"><title>Bioinformatic analysis</title><p>To assign a ChIP-seq peak to each gene, representative transcripts, defined by Cufflinks on the RNA-seq data without any transfection, were used and defined as a peak where there is an overlap by more than 1&#x000a0;bp between 1.5 kbp upstream and 1.5kbp downstream of the transcription start site (TSS). The number of tags per peak was calculated using the wig files generated from MACS and adding all tags in the peak region. For the RefSeq mRNA, we analyzed a total of 6,104 genes for which a peak was observed for both H3K4me3 and RNA polymerase II and for which a positive half-life could be calculated. Wilcoxon&#x02019;s signed ranked test was used to determine the statistical significance between the bins of gene expression and H3K4me3 tags, the bins of RNA half-life and H3K4me3 tags, and the bins of gene expression and RNA half-life. Pearson product&#x02013;moment coefficient was used to calculate the correlation values between log-transformed H3K4me3 tags and log-transformed gene expression. Gene ontology was conducted by R, obtaining the gene ontology database from NCBI, calculating the occurrence of a particular gene ontology (GO) term, followed by calculating the enrichment of a particular GO term in the sample gene-list by hyper-geometric distribution, corrected for multiple testing by Benjamini-Hochberg false-discovery rate. GO data was obtained on 8<sup>th</sup> May 2014. To define eRNAs, we used H3K4me1 and H3K27Ac HeLaS3 data from the ENCODE project. Bedtools [<xref ref-type="bibr" rid="CR46">46</xref>] were used to identify and quantify the mapped reads from siUPF1/siEXOSC5 and siControl BRIC-seq dataset that maps to the H3K4me1 and H3K27Ac regions and not overlapping with 1.5&#x000a0;kb of the entire length of the gene body. The number of mapped reads to a particular region was normalized by the length of the region (to 1 kbp) and by the sequencing depth (to per million). The reads were normalized by GAPDH and eRNA half-lives were calculated as above.</p></sec><sec id="Sec20"><title>Computational simulation and modeling</title><p>The ChIP-seq data was analysed as previously mentioned for H3K4me3 and pol II, and the intensities were calculated by counting the number of tags mapped within: +/&#x02212; 1kbp window centered on the TSS for H3K4me3 and, H3K27Ac, and gene body for H3K27me3 and H3K36me3. The log-transformed and standardized (mean&#x02009;=&#x02009;0 and standard deviation&#x02009;=&#x02009;1) histone intensities were used to build a linear model [<xref ref-type="bibr" rid="CR7">7</xref>].<disp-formula id="Equa"><alternatives><tex-math id="M1">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$ \mathrm{Model}\ \mathrm{A}:\ \mathrm{mRNA}\ \mathrm{level} \sim {b}_0+{b}_1{N}_{\mathrm{H}3\mathrm{K}4\mathrm{me}3}+{b}_2{N}_{\mathrm{H}3\mathrm{K}27\mathrm{A}\mathrm{c}}+{b}_3{N}_{\mathrm{H}3\mathrm{K}27\mathrm{me}3}+{b}_4{N}_{\mathrm{H}3\mathrm{K}36\mathrm{me}3}+e $$\end{document}</tex-math><mml:math id="M2"><mml:mi mathvariant="normal">Model</mml:mi><mml:mspace width="0.25em"/><mml:mi mathvariant="normal">A</mml:mi><mml:mo>:</mml:mo><mml:mspace width="0.25em"/><mml:mi mathvariant="normal">mRNA</mml:mi><mml:mspace width="0.25em"/><mml:mi mathvariant="normal">level</mml:mi><mml:mo>~</mml:mo><mml:mspace width="0.25em"/><mml:msub><mml:mi>b</mml:mi><mml:mn>0</mml:mn></mml:msub><mml:mo>+</mml:mo><mml:msub><mml:mi>b</mml:mi><mml:mn>1</mml:mn></mml:msub><mml:msub><mml:mi>N</mml:mi><mml:mrow><mml:mi mathvariant="normal">H</mml:mi><mml:mn>3</mml:mn><mml:mi mathvariant="normal">K</mml:mi><mml:mn>4</mml:mn><mml:mi mathvariant="normal">me</mml:mi><mml:mn>3</mml:mn></mml:mrow></mml:msub><mml:mo>+</mml:mo><mml:msub><mml:mi>b</mml:mi><mml:mn>2</mml:mn></mml:msub><mml:msub><mml:mi>N</mml:mi><mml:mrow><mml:mi mathvariant="normal">H</mml:mi><mml:mn>3</mml:mn><mml:mi mathvariant="normal">K</mml:mi><mml:mn>27</mml:mn><mml:mi mathvariant="normal">A</mml:mi><mml:mi mathvariant="normal">c</mml:mi></mml:mrow></mml:msub><mml:mo>+</mml:mo><mml:msub><mml:mi>b</mml:mi><mml:mn>3</mml:mn></mml:msub><mml:msub><mml:mi>N</mml:mi><mml:mrow><mml:mi mathvariant="normal">H</mml:mi><mml:mn>3</mml:mn><mml:mi mathvariant="normal">K</mml:mi><mml:mn>27</mml:mn><mml:mi mathvariant="normal">me</mml:mi><mml:mn>3</mml:mn></mml:mrow></mml:msub><mml:mo>+</mml:mo><mml:msub><mml:mi>b</mml:mi><mml:mn>4</mml:mn></mml:msub><mml:msub><mml:mi>N</mml:mi><mml:mrow><mml:mi mathvariant="normal">H</mml:mi><mml:mn>3</mml:mn><mml:mi mathvariant="normal">K</mml:mi><mml:mn>36</mml:mn><mml:mi mathvariant="normal">me</mml:mi><mml:mn>3</mml:mn></mml:mrow></mml:msub><mml:mo>+</mml:mo><mml:mi>e</mml:mi></mml:math><graphic xlink:href="12864_2015_1358_Article_Equa.gif" position="anchor"/></alternatives></disp-formula><disp-formula id="Equb"><alternatives><tex-math id="M3">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$ \mathrm{Model}\ \mathrm{B}:\ \mathrm{mRNA}\ \mathrm{level} \sim {b}_0+{b}_1{N}_{\mathrm{H}3\mathrm{K}4\mathrm{me}3}+{b}_2{N}_{\mathrm{H}3\mathrm{K}27\mathrm{A}\mathrm{c}}+{b}_3{N}_{\mathrm{H}3\mathrm{K}27\mathrm{me}3}+{b}_4{N}_{\mathrm{H}3\mathrm{K}36\mathrm{me}3}+{b}_5\mathrm{half}\hbox{-} \mathrm{life}+e $$\end{document}</tex-math><mml:math id="M4"><mml:mi mathvariant="normal">Model</mml:mi><mml:mspace width="0.25em"/><mml:mi mathvariant="normal">B</mml:mi><mml:mo>:</mml:mo><mml:mspace width="0.25em"/><mml:mi mathvariant="normal">mRNA</mml:mi><mml:mspace width="0.25em"/><mml:mi mathvariant="normal">level</mml:mi><mml:mspace width="0.25em"/><mml:mo>~</mml:mo><mml:msub><mml:mi>b</mml:mi><mml:mn>0</mml:mn></mml:msub><mml:mo>+</mml:mo><mml:msub><mml:mi>b</mml:mi><mml:mn>1</mml:mn></mml:msub><mml:msub><mml:mi>N</mml:mi><mml:mrow><mml:mi mathvariant="normal">H</mml:mi><mml:mn>3</mml:mn><mml:mi mathvariant="normal">K</mml:mi><mml:mn>4</mml:mn><mml:mi mathvariant="normal">me</mml:mi><mml:mn>3</mml:mn></mml:mrow></mml:msub><mml:mo>+</mml:mo><mml:msub><mml:mi>b</mml:mi><mml:mn>2</mml:mn></mml:msub><mml:msub><mml:mi>N</mml:mi><mml:mrow><mml:mi mathvariant="normal">H</mml:mi><mml:mn>3</mml:mn><mml:mi mathvariant="normal">K</mml:mi><mml:mn>27</mml:mn><mml:mi mathvariant="normal">A</mml:mi><mml:mi mathvariant="normal">c</mml:mi></mml:mrow></mml:msub><mml:mo>+</mml:mo><mml:msub><mml:mi>b</mml:mi><mml:mn>3</mml:mn></mml:msub><mml:msub><mml:mi>N</mml:mi><mml:mrow><mml:mi mathvariant="normal">H</mml:mi><mml:mn>3</mml:mn><mml:mi mathvariant="normal">K</mml:mi><mml:mn>27</mml:mn><mml:mi mathvariant="normal">me</mml:mi><mml:mn>3</mml:mn></mml:mrow></mml:msub><mml:mo>+</mml:mo><mml:msub><mml:mi>b</mml:mi><mml:mn>4</mml:mn></mml:msub><mml:msub><mml:mi>N</mml:mi><mml:mrow><mml:mi mathvariant="normal">H</mml:mi><mml:mn>3</mml:mn><mml:mi mathvariant="normal">K</mml:mi><mml:mn>36</mml:mn><mml:mi mathvariant="normal">me</mml:mi><mml:mn>3</mml:mn></mml:mrow></mml:msub><mml:mo>+</mml:mo><mml:msub><mml:mi>b</mml:mi><mml:mn>5</mml:mn></mml:msub><mml:mi mathvariant="normal">half</mml:mi><mml:mo>&#x02010;</mml:mo><mml:mi mathvariant="normal">life</mml:mi><mml:mo>+</mml:mo><mml:mi>e</mml:mi></mml:math><graphic xlink:href="12864_2015_1358_Article_Equb.gif" position="anchor"/></alternatives></disp-formula></p><p>Where <italic>N</italic> is studentized read coverage, mRNA level is log transformed RPKM, half-life is log transformed decay constant <inline-formula id="IEq1"><alternatives><tex-math id="M5">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$ \left(\lambda =\frac{ \log (2)}{\mathrm{half}\hbox{-} \mathrm{life}}\right) $$\end{document}</tex-math><mml:math id="M6"><mml:mfenced close=")" open="("><mml:mrow><mml:mi>&#x003bb;</mml:mi><mml:mo>=</mml:mo><mml:mfrac><mml:mrow><mml:mo>log</mml:mo><mml:mfenced close=")" open="("><mml:mn>2</mml:mn></mml:mfenced></mml:mrow><mml:mrow><mml:mi mathvariant="normal">half</mml:mi><mml:mo>&#x02010;</mml:mo><mml:mi mathvariant="normal">life</mml:mi></mml:mrow></mml:mfrac></mml:mrow></mml:mfenced></mml:math><inline-graphic xlink:href="12864_2015_1358_Article_IEq1.gif"/></alternatives></inline-formula> and <italic>e</italic> is the residual error.</p></sec><sec id="Sec21"><title>Analysis using ENCODE data</title><p>H3K4me3, H3K36me3, pol II and RNA-seq data for seven cell types were obtained from ENCODE and DLD-1 from DBTSS (see Additional file <xref rid="MOESM1" ref-type="media">1</xref>: Figure S5). Average enrichment for the H3K4me3 data ChIP-seq data was used to compare against the gene expression values.</p></sec><sec id="Sec22"><title>Western blot analysis</title><p>Cell lysates were prepared using RIPA buffer (50&#x000a0;mM Tris-Cl, pH&#x000a0;7.4, 150&#x000a0;mM NaCl, 5&#x000a0;mM EDTA, 1% Nonidet P-40, 1% sodium deoxycholate, 0.1% SDS, 1% proteinase inhibitor cocktail [Sigma-Aldrich, St. Louis, MO]). Proteins were resolved by 10% SDS PAGE and transferred to a polyvinylidene difluoride membrane. Membranes were incubated with the indicated primary antibodies, followed by incubation with anti-mouse or anti-rabbit secondary antibodies conjugated to horseradish peroxidase (HRP). After addition of the HRP substrate, the chemiluminescence signal was detected with a Luminescent Image Analyzer LAS-4000 (Fujifilm, Tokyo, Japan). Antibodies used for immunoblotting were as follows: rabbit anti-UPF1 (Abcam), rabbit anti-STAU1 (kindly provided by Dr. Ort&#x000ed;n), rabbit anti-EXOSC5 antibody (Sigma-Aldrich, SAB200439), rabbit anti-actin (Sigma-Aldrich, A1978), and rabbit anti-tubulin (MBL, Nagoya, Japan).</p></sec><sec id="Sec23"><title>Availability of supporting data</title><p>Supporting sequence data are available through DDBJ under the accession number [DDBJ: DRA001215] and [DDBJ:DRA002961] and URL links to the sequencing data are available from <ext-link ext-link-type="uri" xlink:href="http://trace.ddbj.nig.ac.jp/DRASearch/submission?acc=DRA001215">http://trace.ddbj.nig.ac.jp/DRASearch/submission?acc=DRA001215</ext-link> and <ext-link ext-link-type="uri" xlink:href="http://trace.ddbj.nig.ac.jp/DRASearch/submission?acc=DRA002961">http://trace.ddbj.nig.ac.jp/DRASearch/submission?acc=DRA002961</ext-link>.</p></sec></sec></body><back><app-group><app id="App1"><sec id="Sec24"><title>Additional files</title><p><media position="anchor" xlink:href="12864_2015_1358_MOESM1_ESM.pptx" id="MOESM1"><label>Additional file 1: Figure S1.</label><caption><p>Statistics of the ChIP-seq, RNA-seq and BRIC-seq data used in the present study. a) The figure shows that the percentage of genes with high intensity H3K4me3 peaks increases as RPKM increases, whereas percentage of genes with low intensity H3K4me3 peaks or genes without peaks decrease as RPKM increases. b) ChIP-seq statistics. The number of peaks in ChIP-seq were called by MACS, irrespective of Refseq gene models. c) RNA-seq statistics. d) BRIC-seq statistics. <bold>Figure S2.</bold> ActD validation of BRIC-seq. <bold>Figure S3.</bold> Computational simulation on to the effect of siRNA knockdown to UPF1, EXOSC5 and STAU1. <bold>Figure S4.</bold> Expression level and RNA stability of HIC1 and ZNF783 transcription factors in indicated cells. <bold>Figure S5.</bold> List of ENCODE and DBTSS datasets used in this study. <bold>Figure S6.</bold> Scatterplots of the H3K4me3 intensities against gene expression values Y-axis indicates the H3K4me3 intensities and x-axis indicates gene expression. <bold>Figure S7.</bold> Number of ChIP (+)/RNA (&#x02212;) genes in different cell types from ENCODE and DBTSS. <bold>Figure S8.</bold> Knockdown results for EXOSC5 and STAU1. <bold>Figure S9.</bold> List of siRNAs used for knockdown and oligonucleotides used for qPCR. <bold>Figure S10.</bold> Equations used in modeling the transcript levels. <bold>Figure S11.</bold> Statistics of the analysis conducted on ENCODE and DBTSS data. <bold>Figure 12.</bold> Boxplots show the nuclear to cytoplasm ratio of ENCODE and DBTSS data.</p></caption></media><media position="anchor" xlink:href="12864_2015_1358_MOESM2_ESM.xlsx" id="MOESM2"><label>Additional file 2: Table S1.</label><caption><p>Statistics into the correlation between ChIP-seq and RNA-seq. <bold>Table S2.</bold> RNAs potentially controlled by RNA turnover. <bold>Table S3.</bold> RNAs potentially controlled by UPF1, EXOSC5 and STAU1 as determined by data in the present study. <bold>Table S4.</bold> List of zinc figure proteins under the control of UPF1. <bold>Table S5.</bold> List of genes that may be controlled by RNA turnover from ENCODE data. <bold>Table S6.</bold> eRNAs coordinates that are potentially controlled by UPF1 (a) and EXOSC5 (b).</p></caption></media></p></sec></app></app-group><glossary><title>Abbreviations</title><def-list><def-list><def-item><term>bp</term><def><p>Base pair</p></def></def-item><def-item><term>BRIC</term><def><p>5&#x02032;-bromouridine immunoprecipitation chase</p></def></def-item><def-item><term>BrU</term><def><p>5&#x02032;-bromouridine</p></def></def-item><def-item><term>ChIP</term><def><p>Chromatin immunoprecipitation</p></def></def-item><def-item><term>eRNA</term><def><p>Enhancer RNA</p></def></def-item><def-item><term>GO</term><def><p>Gene ontology</p></def></def-item><def-item><term>H3K4me1</term><def><p>Histone H3 mono-methylated lysine 4</p></def></def-item><def-item><term>H3K4me3</term><def><p>Histone H3 tri-methylated lysine 4</p></def></def-item><def-item><term>H3K27ac</term><def><p>Histone acetylated lysine 27</p></def></def-item><def-item><term>H3K36me3</term><def><p>Histone tri-methylated lysine 36</p></def></def-item><def-item><term>kbp</term><def><p>Kilobasepairs</p></def></def-item><def-item><term>lincRNA</term><def><p>Long intergenic non-coding</p></def></def-item><def-item><term>pol II</term><def><p>RNA polymerase II RNA</p></def></def-item><def-item><term>RPKM</term><def><p>Reads per kilobase per million mapped reads</p></def></def-item></def-list></def-list></glossary><fn-group><fn><p><bold>Competing interests</bold></p><p>The authors declare that they have no competing interests.</p></fn><fn><p><bold>Authors&#x02019; contributions</bold></p><p>SM carried out the studies and wrote the manuscript. NI conducted RIP-qPCR validation and generated the knockdown data. HT generated the knockdown data and TI conducted the modeling. KM generated the ChIP-seq data. RM, KI and MK generated the BRIC-seq data. TY conducted the transcription factor binding consensus enrichment SS helped with the design and discussion of the study. YS and NA designed the study and participated in designing and writing the manuscript. All authors read and approved the final manuscript.</p></fn></fn-group><ack><title>Acknowledgements</title><p>We thank Fusano Todokoro and Terumi Horiuchi for their help in the data analyses, and Kiyomi Imamura for help with the ChIP-seq library construction. We would like to thank ENCODE project for their expression and chromatin data. This work was supported financially by MEXT KAKENHI Grant Number 221S0002, the Funding Program for World-Leading Innovative R&#x00026;D on Science and Technology of the Japan Society for the Promotion of Science, and a Grant-in-Aid for Scientific Research on Innovative Areas Functional Machinery for Non-Coding RNAs from the Ministry of Education, Culture, Sports, Science and Technology of Japan.</p></ack><ref-list id="Bib1"><title>References</title><ref id="CR1"><label>1.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Moore</surname><given-names>MJ</given-names></name></person-group><article-title>From birth to death: the complex lives of eukaryotic mRNAs</article-title><source>Science</source><year>2005</year><volume>309</volume><fpage>1514</fpage><lpage>8</lpage><pub-id pub-id-type="doi">10.1126/science.1111443</pub-id><?supplied-pmid 16141059?><pub-id pub-id-type="pmid">16141059</pub-id></element-citation></ref><ref id="CR2"><label>2.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mikkelsen</surname><given-names>TS</given-names></name><name><surname>Ku</surname><given-names>M</given-names></name><name><surname>Jaffe</surname><given-names>DB</given-names></name><name><surname>Issac</surname><given-names>B</given-names></name><name><surname>Lieberman</surname><given-names>E</given-names></name><name><surname>Giannoukos</surname><given-names>G</given-names></name><etal/></person-group><article-title>Genome-wide maps of chromatin state in pluripotent and lineage-committed cells</article-title><source>Nature</source><year>2007</year><volume>448</volume><fpage>553</fpage><lpage>60</lpage><pub-id pub-id-type="doi">10.1038/nature06008</pub-id><?supplied-pmid 17603471?><pub-id pub-id-type="pmid">17603471</pub-id></element-citation></ref><ref id="CR3"><label>3.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Koch</surname><given-names>CM</given-names></name><name><surname>Andrews</surname><given-names>RM</given-names></name><name><surname>Flicek</surname><given-names>P</given-names></name><name><surname>Dillon</surname><given-names>SC</given-names></name><name><surname>Kara&#x000f6;z</surname><given-names>U</given-names></name><name><surname>Clelland</surname><given-names>GK</given-names></name><etal/></person-group><article-title>The landscape of histone modifications across 1% of the human genome in five human cell lines</article-title><source>Genome Res</source><year>2007</year><volume>17</volume><fpage>691</fpage><lpage>707</lpage><pub-id pub-id-type="doi">10.1101/gr.5704207</pub-id><?supplied-pmid 17567990?><pub-id pub-id-type="pmid">17567990</pub-id></element-citation></ref><ref id="CR4"><label>4.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dong</surname><given-names>X</given-names></name><name><surname>Greven</surname><given-names>MC</given-names></name><name><surname>Kundaje</surname><given-names>A</given-names></name><name><surname>Djebali</surname><given-names>S</given-names></name><name><surname>Brown</surname><given-names>JB</given-names></name><name><surname>Cheng</surname><given-names>C</given-names></name><etal/></person-group><article-title>Modeling gene expression using chromatin features in various cellular contexts</article-title><source>Genome Biol</source><year>2012</year><volume>13</volume><fpage>R53</fpage><pub-id pub-id-type="doi">10.1186/gb-2012-13-9-r53</pub-id><?supplied-pmid 22950368?><pub-id pub-id-type="pmid">22950368</pub-id></element-citation></ref><ref id="CR5"><label>5.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Park</surname><given-names>PJ</given-names></name></person-group><article-title>ChIP-seq: advantages and challenges of a maturing technology</article-title><source>Nat Rev Genet</source><year>2009</year><volume>10</volume><fpage>669</fpage><lpage>80</lpage><pub-id pub-id-type="doi">10.1038/nrg2641</pub-id><?supplied-pmid 19736561?><pub-id pub-id-type="pmid">19736561</pub-id></element-citation></ref><ref id="CR6"><label>6.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Karli&#x00107;</surname><given-names>R</given-names></name><name><surname>Chung</surname><given-names>H-R</given-names></name><name><surname>Chung</surname><given-names>HR</given-names></name><name><surname>Lasserre</surname><given-names>J</given-names></name><name><surname>Lasserre</surname><given-names>J</given-names></name><etal/></person-group><article-title>Histone modification levels are predictive for gene expression</article-title><source>Proc Natl Acad Sci</source><year>2010</year><volume>107</volume><fpage>2926</fpage><lpage>31</lpage><pub-id pub-id-type="doi">10.1073/pnas.0909344107</pub-id><?supplied-pmid 20133639?><pub-id pub-id-type="pmid">20133639</pub-id></element-citation></ref><ref id="CR7"><label>7.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>C</given-names></name><name><surname>Tian</surname><given-names>R</given-names></name><name><surname>Zhao</surname><given-names>Q</given-names></name><name><surname>Xu</surname><given-names>H</given-names></name><name><surname>Meyer</surname><given-names>CA</given-names></name><name><surname>Li</surname><given-names>C</given-names></name><etal/></person-group><article-title>Computational inference of mRNA stability from histone modification and transcriptome profiles</article-title><source>Nucleic Acids Res</source><year>2012</year><volume>40</volume><fpage>6414</fpage><lpage>23</lpage><pub-id pub-id-type="doi">10.1093/nar/gks304</pub-id><?supplied-pmid 22495509?><pub-id pub-id-type="pmid">22495509</pub-id></element-citation></ref><ref id="CR8"><label>8.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Imamachi</surname><given-names>N</given-names></name></person-group><article-title>Up-frameshift protein 1 (UPF1): Multitalented entertainer in RNA decay</article-title><source>Drug Discov Ther</source><year>2012</year><volume>6</volume><fpage>55</fpage><lpage>61</lpage><?supplied-pmid 22622014?><pub-id pub-id-type="pmid">22622014</pub-id></element-citation></ref><ref id="CR9"><label>9.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yamashita</surname><given-names>A</given-names></name></person-group><article-title>Role of SMG&#x02010;1&#x02010;mediated Upf1 phosphorylation in mammalian nonsense&#x02010;mediated mRNA decay</article-title><source>Genes Cells</source><year>2013</year><volume>18</volume><fpage>161</fpage><lpage>75</lpage><pub-id pub-id-type="doi">10.1111/gtc.12033</pub-id><?supplied-pmid 23356578?><pub-id pub-id-type="pmid">23356578</pub-id></element-citation></ref><ref id="CR10"><label>10.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schweingruber</surname><given-names>C</given-names></name><name><surname>Rufener</surname><given-names>SC</given-names></name><name><surname>Z&#x000fc;nd</surname><given-names>D</given-names></name><name><surname>Yamashita</surname><given-names>A</given-names></name><name><surname>M&#x000fc;hlemann</surname><given-names>O</given-names></name></person-group><article-title>Biochimica et Biophysica Acta</article-title><source>Gene Regul Mech</source><year>2013</year><volume>1829</volume><fpage>612</fpage><lpage>23</lpage></element-citation></ref><ref id="CR11"><label>11.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mendell</surname><given-names>JT</given-names></name><name><surname>Sharifi</surname><given-names>NA</given-names></name><name><surname>Meyers</surname><given-names>JL</given-names></name><name><surname>Martinez-Murillo</surname><given-names>F</given-names></name><name><surname>Dietz</surname><given-names>HC</given-names></name></person-group><article-title>Nonsense surveillance regulates expression of diverse classes of mammalian transcripts and mutes genomic noise</article-title><source>Nat Genet</source><year>2004</year><volume>36</volume><fpage>1073</fpage><lpage>8</lpage><pub-id pub-id-type="doi">10.1038/ng1429</pub-id><?supplied-pmid 15448691?><pub-id pub-id-type="pmid">15448691</pub-id></element-citation></ref><ref id="CR12"><label>12.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Maquat</surname><given-names>LE</given-names></name><name><surname>Gong</surname><given-names>C</given-names></name></person-group><article-title>Gene expression networks: competing mRNA decay pathways in mammalian cells</article-title><source>Biochem Soc Trans</source><year>2009</year><volume>37</volume><fpage>1287</fpage><pub-id pub-id-type="doi">10.1042/BST0371287</pub-id><?supplied-pmid 19909264?><pub-id pub-id-type="pmid">19909264</pub-id></element-citation></ref><ref id="CR13"><label>13.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pan</surname><given-names>Q</given-names></name></person-group><article-title>Quantitative microarray profiling provides evidence against widespread coupling of alternative splicing with nonsense-mediated mRNA decay to control gene expression</article-title><source>Genes Dev</source><year>2006</year><volume>20</volume><fpage>153</fpage><lpage>8</lpage><pub-id pub-id-type="doi">10.1101/gad.1382806</pub-id><?supplied-pmid 16418482?><pub-id pub-id-type="pmid">16418482</pub-id></element-citation></ref><ref id="CR14"><label>14.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chan</surname><given-names>W-K</given-names></name><name><surname>Bhalla</surname><given-names>AD</given-names></name><name><surname>Le Hir</surname><given-names>H</given-names></name><name><surname>Nguyen</surname><given-names>LS</given-names></name><name><surname>Huang</surname><given-names>L</given-names></name><name><surname>G&#x000e9;cz</surname><given-names>J</given-names></name><etal/></person-group><article-title>A UPF3-mediated regulatory switch that maintains RNA surveillance</article-title><source>Nat Struct Mol Biol</source><year>2009</year><volume>16</volume><fpage>747</fpage><lpage>53</lpage><pub-id pub-id-type="doi">10.1038/nsmb.1612</pub-id><?supplied-pmid 19503078?><pub-id pub-id-type="pmid">19503078</pub-id></element-citation></ref><ref id="CR15"><label>15.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bruno</surname><given-names>IG</given-names></name><name><surname>Karam</surname><given-names>R</given-names></name><name><surname>Huang</surname><given-names>L</given-names></name><name><surname>Bhardwaj</surname><given-names>A</given-names></name><name><surname>Lou</surname><given-names>CH</given-names></name><name><surname>Shum</surname><given-names>EY</given-names></name><etal/></person-group><article-title>Identification of a MicroRNAthat activates gene expressionby repressing nonsense-mediated RNA decay</article-title><source>Mol Cell</source><year>2011</year><volume>42</volume><fpage>500</fpage><lpage>10</lpage><pub-id pub-id-type="doi">10.1016/j.molcel.2011.04.018</pub-id><?supplied-pmid 21596314?><pub-id pub-id-type="pmid">21596314</pub-id></element-citation></ref><ref id="CR16"><label>16.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kim</surname><given-names>YK</given-names></name><name><surname>Furic</surname><given-names>L</given-names></name><name><surname>DesGroseillers</surname><given-names>L</given-names></name><name><surname>Maquat</surname><given-names>LE</given-names></name></person-group><article-title>Mammalian Staufen1 recruits Upf1 to specific mRNA 3&#x02032;UTRs so as to elicit mRNA decay</article-title><source>Cell</source><year>2005</year><volume>120</volume><fpage>195</fpage><lpage>208</lpage><pub-id pub-id-type="doi">10.1016/j.cell.2004.11.050</pub-id><?supplied-pmid 15680326?><pub-id pub-id-type="pmid">15680326</pub-id></element-citation></ref><ref id="CR17"><label>17.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kaygun</surname><given-names>H</given-names></name><name><surname>Marzluff</surname><given-names>WF</given-names></name></person-group><article-title>Regulated degradation of replication-dependent histone mRNAs requires both ATR and Upf1</article-title><source>Nat Struct Mol Biol</source><year>2005</year><volume>12</volume><fpage>794</fpage><lpage>800</lpage><pub-id pub-id-type="doi">10.1038/nsmb972</pub-id><?supplied-pmid 16086026?><pub-id pub-id-type="pmid">16086026</pub-id></element-citation></ref><ref id="CR18"><label>18.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kim</surname><given-names>YK</given-names></name><name><surname>Furic</surname><given-names>L</given-names></name><name><surname>Parisien</surname><given-names>M</given-names></name><name><surname>Major</surname><given-names>F</given-names></name><name><surname>DesGroseillers</surname><given-names>L</given-names></name><name><surname>Maquat</surname><given-names>LE</given-names></name></person-group><article-title>Staufen1 regulates diverse classes of mammalian transcripts</article-title><source>EMBO J</source><year>2007</year><volume>26</volume><fpage>2670</fpage><lpage>81</lpage><pub-id pub-id-type="doi">10.1038/sj.emboj.7601712</pub-id><?supplied-pmid 17510634?><pub-id pub-id-type="pmid">17510634</pub-id></element-citation></ref><ref id="CR19"><label>19.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chlebowski</surname><given-names>A</given-names></name><name><surname>Lubas</surname><given-names>M</given-names></name><name><surname>Jensen</surname><given-names>TH</given-names></name><name><surname>Dziembowski</surname><given-names>A</given-names></name></person-group><article-title>RNA decay machines: the exosome</article-title><source>Biochim Biophys Acta Gene Regul Mech</source><year>2013</year><volume>1829</volume><fpage>552</fpage><lpage>60</lpage><pub-id pub-id-type="doi">10.1016/j.bbagrm.2013.01.006</pub-id></element-citation></ref><ref id="CR20"><label>20.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schneider</surname><given-names>C</given-names></name><name><surname>Tollervey</surname><given-names>D</given-names></name></person-group><article-title>Threading the barrel of the RNA exosome</article-title><source>Trends Biochem Sci</source><year>2013</year><volume>38</volume><fpage>485</fpage><lpage>93</lpage><pub-id pub-id-type="doi">10.1016/j.tibs.2013.06.013</pub-id><?supplied-pmid 23910895?><pub-id pub-id-type="pmid">23910895</pub-id></element-citation></ref><ref id="CR21"><label>21.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Imamachi</surname><given-names>N</given-names></name><name><surname>Tani</surname><given-names>H</given-names></name><name><surname>Mizutani</surname><given-names>R</given-names></name><name><surname>Imamura</surname><given-names>K</given-names></name><name><surname>Irie</surname><given-names>T</given-names></name><name><surname>Suzuki</surname><given-names>Y</given-names></name><name><surname>Akimitsu</surname><given-names>N</given-names></name></person-group><article-title>BRIC-seq: A genome-wide approach for determining RNA stability in mammalian cells</article-title><source>Methods</source><year>2014</year><volume>67</volume><fpage>55</fpage><lpage>63</lpage><pub-id pub-id-type="doi">10.1016/j.ymeth.2013.07.014</pub-id><?supplied-pmid 23872059?><pub-id pub-id-type="pmid">23872059</pub-id></element-citation></ref><ref id="CR22"><label>22.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tani</surname><given-names>H</given-names></name><name><surname>Mizutani</surname><given-names>R</given-names></name><name><surname>Salam</surname><given-names>KA</given-names></name><name><surname>Tano</surname><given-names>K</given-names></name><name><surname>Ijiri</surname><given-names>K</given-names></name><name><surname>Wakamatsu</surname><given-names>A</given-names></name><etal/></person-group><article-title>Genome-wide determination of RNA stability reveals hundreds of short-lived noncoding transcripts in mammals</article-title><source>Genome Res</source><year>2012</year><volume>22</volume><fpage>947</fpage><lpage>56</lpage><pub-id pub-id-type="doi">10.1101/gr.130559.111</pub-id><?supplied-pmid 22369889?><pub-id pub-id-type="pmid">22369889</pub-id></element-citation></ref><ref id="CR23"><label>23.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tani</surname><given-names>H</given-names></name><name><surname>Imamachi</surname><given-names>N</given-names></name><name><surname>Salam</surname><given-names>KA</given-names></name><name><surname>Mizutani</surname><given-names>R</given-names></name><name><surname>Ijiri</surname><given-names>K</given-names></name><name><surname>Irie</surname><given-names>T</given-names></name><etal/></person-group><article-title>Identification of hundreds of novel UPF1 target transcripts by direct determination of whole transcriptome stability</article-title><source>RNA Biol</source><year>2012</year><volume>9</volume><fpage>1370</fpage><lpage>9</lpage><pub-id pub-id-type="doi">10.4161/rna.22360</pub-id><?supplied-pmid 23064114?><pub-id pub-id-type="pmid">23064114</pub-id></element-citation></ref><ref id="CR24"><label>24.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>Y</given-names></name><name><surname>Liu</surname><given-names>T</given-names></name><name><surname>Meyer</surname><given-names>CA</given-names></name><name><surname>Eeckhoute</surname><given-names>J</given-names></name><name><surname>Johnson</surname><given-names>DS</given-names></name><name><surname>Bernstein</surname><given-names>BE</given-names></name><etal/></person-group><article-title>Model-based analysis of ChIP-Seq (MACS)</article-title><source>Genome Biol</source><year>2008</year><volume>9</volume><fpage>R137</fpage><pub-id pub-id-type="doi">10.1186/gb-2008-9-9-r137</pub-id><?supplied-pmid 18798982?><pub-id pub-id-type="pmid">18798982</pub-id></element-citation></ref><ref id="CR25"><label>25.</label><element-citation publication-type="journal"><person-group person-group-type="author"><collab>The ENCODE Project Consortium</collab></person-group><article-title>A user&#x02019;s guide to the encyclopedia of DNA elements (ENCODE)</article-title><source>PLoS Biol</source><year>2011</year><volume>9</volume><fpage>e1001046</fpage><pub-id pub-id-type="doi">10.1371/journal.pbio.1001046</pub-id><pub-id pub-id-type="pmid">21526222</pub-id></element-citation></ref><ref id="CR26"><label>26.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yamashita</surname><given-names>R</given-names></name><name><surname>Sugano</surname><given-names>S</given-names></name><name><surname>Suzuki</surname><given-names>Y</given-names></name><name><surname>Nakai</surname><given-names>K</given-names></name></person-group><article-title>DBTSS: DataBase of Transcriptional Start Sites progress report in 2012</article-title><source>Nucleic Acids Res</source><year>2012</year><volume>40</volume><issue>Database issue</issue><fpage>D150</fpage><lpage>4</lpage><pub-id pub-id-type="doi">10.1093/nar/gkr1005</pub-id><?supplied-pmid 22086958?><pub-id pub-id-type="pmid">22086958</pub-id></element-citation></ref><ref id="CR27"><label>27.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kouzarides</surname><given-names>T</given-names></name></person-group><article-title>Chromatin modifications and their function</article-title><source>Cell</source><year>2007</year><volume>128</volume><fpage>693</fpage><lpage>705</lpage><pub-id pub-id-type="doi">10.1016/j.cell.2007.02.005</pub-id><?supplied-pmid 17320507?><pub-id pub-id-type="pmid">17320507</pub-id></element-citation></ref><ref id="CR28"><label>28.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cabili</surname><given-names>MN</given-names></name><name><surname>Trapnell</surname><given-names>C</given-names></name><name><surname>Goff</surname><given-names>L</given-names></name><name><surname>Koziol</surname><given-names>M</given-names></name><name><surname>Tazon-Vega</surname><given-names>B</given-names></name><name><surname>Regev</surname><given-names>A</given-names></name><etal/></person-group><article-title>Integrative annotation of human large intergenic noncoding RNAs reveals global properties and specific subclasses</article-title><source>Genes Dev</source><year>2011</year><volume>25</volume><fpage>1915</fpage><lpage>27</lpage><pub-id pub-id-type="doi">10.1101/gad.17446611</pub-id><?supplied-pmid 21890647?><pub-id pub-id-type="pmid">21890647</pub-id></element-citation></ref><ref id="CR29"><label>29.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tani</surname><given-names>H</given-names></name><name><surname>Torimura</surname><given-names>M</given-names></name><name><surname>Akimitsu</surname><given-names>N</given-names></name></person-group><article-title>The RNA degradation pathway regulates the function of GAS5 a Non-coding RNA in mammalian cells</article-title><source>PLoS One</source><year>2013</year><volume>8</volume><fpage>e55684</fpage><pub-id pub-id-type="doi">10.1371/journal.pone.0055684</pub-id><?supplied-pmid 23383264?><pub-id pub-id-type="pmid">23383264</pub-id></element-citation></ref><ref id="CR30"><label>30.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kurihara</surname><given-names>Y</given-names></name><name><surname>Matsui</surname><given-names>A</given-names></name><name><surname>Hanada</surname><given-names>K</given-names></name><name><surname>Kawashima</surname><given-names>M</given-names></name><name><surname>Ishida</surname><given-names>J</given-names></name><name><surname>Morosawa</surname><given-names>T</given-names></name><etal/></person-group><article-title>Genome-wide suppression of aberrant mRNA-like noncoding RNAs by NMD in Arabidopsis</article-title><source>Proc Natl Acad Sci</source><year>2009</year><volume>106</volume><fpage>2453</fpage><lpage>8</lpage><pub-id pub-id-type="doi">10.1073/pnas.0808902106</pub-id><?supplied-pmid 19181858?><pub-id pub-id-type="pmid">19181858</pub-id></element-citation></ref><ref id="CR31"><label>31.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Haimovich</surname><given-names>G</given-names></name><name><surname>Medina</surname><given-names>DA</given-names></name><name><surname>Causse</surname><given-names>SZ</given-names></name><name><surname>Garber</surname><given-names>M</given-names></name><name><surname>Mill&#x000e1;n-Zambrano</surname><given-names>G</given-names></name><name><surname>Barkai</surname><given-names>O</given-names></name><etal/></person-group><article-title>Gene expression is circular: factors for mRNA degradation also foster mRNA synthesis</article-title><source>Cell</source><year>2013</year><volume>153</volume><fpage>1000</fpage><lpage>11</lpage><pub-id pub-id-type="doi">10.1016/j.cell.2013.05.012</pub-id><?supplied-pmid 23706738?><pub-id pub-id-type="pmid">23706738</pub-id></element-citation></ref><ref id="CR32"><label>32.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kontoyiannis</surname><given-names>D</given-names></name><name><surname>Pasparakis</surname><given-names>M</given-names></name><name><surname>Pizarro</surname><given-names>TT</given-names></name><name><surname>Cominelli</surname><given-names>F</given-names></name><name><surname>Kollias</surname><given-names>G</given-names></name></person-group><article-title>Impaired on/off regulation of TNF biosynthesis in mice lacking TNF AU-rich elements: implications for joint and gut-associated immunopathologies</article-title><source>Immunity</source><year>1999</year><volume>10</volume><fpage>387</fpage><lpage>98</lpage><pub-id pub-id-type="doi">10.1016/S1074-7613(00)80038-2</pub-id><?supplied-pmid 10204494?><pub-id pub-id-type="pmid">10204494</pub-id></element-citation></ref><ref id="CR33"><label>33.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Matsushita</surname><given-names>K</given-names></name><name><surname>Takeuchi</surname><given-names>O</given-names></name><name><surname>Standley</surname><given-names>DM</given-names></name><name><surname>Kumagai</surname><given-names>Y</given-names></name><name><surname>Kawagoe</surname><given-names>T</given-names></name><name><surname>Miyake</surname><given-names>T</given-names></name><etal/></person-group><article-title>Zc3h12a is an RNase essential for controlling immune responses by regulating mRNA decay</article-title><source>Nature</source><year>2009</year><volume>458</volume><fpage>1185</fpage><lpage>90</lpage><pub-id pub-id-type="doi">10.1038/nature07924</pub-id><?supplied-pmid 19322177?><pub-id pub-id-type="pmid">19322177</pub-id></element-citation></ref><ref id="CR34"><label>34.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Malecki</surname><given-names>M</given-names></name><name><surname>Viegas</surname><given-names>SC</given-names></name><name><surname>Carneiro</surname><given-names>T</given-names></name><name><surname>Golik</surname><given-names>P</given-names></name><name><surname>Dressaire</surname><given-names>CEM</given-names></name><name><surname>Ferreira</surname><given-names>MG</given-names></name><etal/></person-group><article-title>The exoribonuclease Dis3L2 defines a novel eukaryotic RNA degradation pathway</article-title><source>EMBO J</source><year>2013</year><volume>32</volume><fpage>1842</fpage><lpage>54</lpage><pub-id pub-id-type="doi">10.1038/emboj.2013.63</pub-id><?supplied-pmid 23503588?><pub-id pub-id-type="pmid">23503588</pub-id></element-citation></ref><ref id="CR35"><label>35.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Morris</surname><given-names>MR</given-names></name><name><surname>Astuti</surname><given-names>D</given-names></name><name><surname>Maher</surname><given-names>ER</given-names></name></person-group><article-title>Perlman syndrome: overgrowth, Wilms tumor predisposition and DIS3L2</article-title><source>Am J Med Genet C Semin Med Genet</source><year>2013</year><volume>163C</volume><fpage>106</fpage><lpage>13</lpage><pub-id pub-id-type="doi">10.1002/ajmg.c.31358</pub-id><?supplied-pmid 23613427?><pub-id pub-id-type="pmid">23613427</pub-id></element-citation></ref><ref id="CR36"><label>36.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Clark</surname><given-names>MB</given-names></name><name><surname>Johnston</surname><given-names>RL</given-names></name><name><surname>Inostroza-Ponta</surname><given-names>M</given-names></name><name><surname>Fox</surname><given-names>AH</given-names></name><name><surname>Fortini</surname><given-names>E</given-names></name><name><surname>Moscato</surname><given-names>P</given-names></name><etal/></person-group><article-title>Genome-wide analysis of long noncoding RNA stability</article-title><source>Genome Res</source><year>2012</year><volume>22</volume><fpage>885</fpage><lpage>98</lpage><pub-id pub-id-type="doi">10.1101/gr.131037.111</pub-id><?supplied-pmid 22406755?><pub-id pub-id-type="pmid">22406755</pub-id></element-citation></ref><ref id="CR37"><label>37.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Camblong</surname><given-names>J</given-names></name><name><surname>Iglesias</surname><given-names>N</given-names></name><name><surname>Fickentscher</surname><given-names>C</given-names></name><name><surname>Dieppois</surname><given-names>G</given-names></name><name><surname>Stutz</surname><given-names>F</given-names></name></person-group><article-title>Antisense RNA stabilization induces transcriptional gene silencing via histone deacetylation in S. cerevisiae</article-title><source>Cell</source><year>2007</year><volume>131</volume><fpage>706</fpage><lpage>17</lpage><pub-id pub-id-type="doi">10.1016/j.cell.2007.09.014</pub-id><?supplied-pmid 18022365?><pub-id pub-id-type="pmid">18022365</pub-id></element-citation></ref><ref id="CR38"><label>38.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Berretta</surname><given-names>J</given-names></name><name><surname>Pinskaya</surname><given-names>M</given-names></name><name><surname>Morillon</surname><given-names>A</given-names></name></person-group><article-title>A cryptic unstable transcript mediates transcriptional trans-silencing of the Ty1 retrotransposon in S. cerevisiae</article-title><source>Genes Dev</source><year>2008</year><volume>22</volume><fpage>615</fpage><lpage>26</lpage><pub-id pub-id-type="doi">10.1101/gad.458008</pub-id><?supplied-pmid 18316478?><pub-id pub-id-type="pmid">18316478</pub-id></element-citation></ref><ref id="CR39"><label>39.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>van Dijk</surname><given-names>EL</given-names></name><name><surname>Chen</surname><given-names>CL</given-names></name><name><surname>d&#x02019;Aubenton-Carafa</surname><given-names>Y</given-names></name><name><surname>Gourvennec</surname><given-names>S</given-names></name><name><surname>Kwapisz</surname><given-names>M</given-names></name><name><surname>Roche</surname><given-names>V</given-names></name><etal/></person-group><article-title>XUTs are a class of Xrn1-sensitive antisense regulatory non-coding RNA in yeast</article-title><source>Nature</source><year>2011</year><volume>475</volume><fpage>114</fpage><lpage>7</lpage><pub-id pub-id-type="doi">10.1038/nature10118</pub-id><?supplied-pmid 21697827?><pub-id pub-id-type="pmid">21697827</pub-id></element-citation></ref><ref id="CR40"><label>40.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Trapnell</surname><given-names>C</given-names></name><name><surname>Pachter</surname><given-names>L</given-names></name><name><surname>Salzberg</surname><given-names>SL</given-names></name></person-group><article-title>TopHat: discovering splice junctions with RNA-Seq</article-title><source>Bioinformatics</source><year>2009</year><volume>25</volume><fpage>1105</fpage><lpage>11</lpage><pub-id pub-id-type="doi">10.1093/bioinformatics/btp120</pub-id><?supplied-pmid 19289445?><pub-id pub-id-type="pmid">19289445</pub-id></element-citation></ref><ref id="CR41"><label>41.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pruitt</surname><given-names>KD</given-names></name><name><surname>Tatusova</surname><given-names>T</given-names></name><name><surname>Brown</surname><given-names>GR</given-names></name><name><surname>Maglott</surname><given-names>DR</given-names></name></person-group><article-title>NCBI Reference Sequences (RefSeq): current status, new features and genome annotation policy</article-title><source>Nucleic Acids Res</source><year>2012</year><volume>40</volume><issue>Database issue</issue><fpage>D130</fpage><lpage>5</lpage><pub-id pub-id-type="doi">10.1093/nar/gkr1079</pub-id><?supplied-pmid 22121212?><pub-id pub-id-type="pmid">22121212</pub-id></element-citation></ref><ref id="CR42"><label>42.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Trapnell</surname><given-names>C</given-names></name><name><surname>Williams</surname><given-names>BA</given-names></name><name><surname>Pertea</surname><given-names>G</given-names></name><name><surname>Mortazavi</surname><given-names>A</given-names></name><name><surname>Kwan</surname><given-names>G</given-names></name><name><surname>van Baren</surname><given-names>MJ</given-names></name><etal/></person-group><article-title>Transcript assembly and quantification by RNA-Seq reveals unannotated transcripts and isoform switching during cell differentiation</article-title><source>Nat Biotechnol</source><year>2010</year><volume>28</volume><fpage>516</fpage><lpage>20</lpage><pub-id pub-id-type="doi">10.1038/nbt.1621</pub-id><pub-id pub-id-type="pmid">20436463</pub-id></element-citation></ref><ref id="CR43"><label>43.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kanai</surname><given-names>A</given-names></name><name><surname>Suzuki</surname><given-names>K</given-names></name><name><surname>Tanimoto</surname><given-names>K</given-names></name><name><surname>Mizushima-Sugano</surname><given-names>J</given-names></name><name><surname>Suzuki</surname><given-names>Y</given-names></name><name><surname>Sugano</surname><given-names>S</given-names></name></person-group><article-title>Characterization of STAT6 target genes in human B cells and lung epithelial cells</article-title><source>DNA Res</source><year>2011</year><volume>18</volume><fpage>379</fpage><lpage>92</lpage><pub-id pub-id-type="doi">10.1093/dnares/dsr025</pub-id><?supplied-pmid 21828071?><pub-id pub-id-type="pmid">21828071</pub-id></element-citation></ref><ref id="CR44"><label>44.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tanimoto</surname><given-names>K</given-names></name><name><surname>Tsuchihara</surname><given-names>K</given-names></name><name><surname>Kanai</surname><given-names>A</given-names></name><name><surname>Arauchi</surname><given-names>T</given-names></name><name><surname>Esumi</surname><given-names>H</given-names></name><name><surname>Suzuki</surname><given-names>Y</given-names></name><etal/></person-group><article-title>Genome-wide identification and annotation of HIF-1&#x003b1; binding sites in two cell lines using massively parallel sequencing</article-title><source>HUGO J</source><year>2011</year><volume>4</volume><fpage>35</fpage><lpage>48</lpage><pub-id pub-id-type="doi">10.1007/s11568-011-9150-9</pub-id><pub-id pub-id-type="pmid">22132063</pub-id></element-citation></ref><ref id="CR45"><label>45.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Matsumoto</surname><given-names>K</given-names></name><name><surname>Suzuki</surname><given-names>A</given-names></name><name><surname>Wakaguri</surname><given-names>H</given-names></name><name><surname>Sugano</surname><given-names>S</given-names></name><name><surname>Suzuki</surname><given-names>Y</given-names></name></person-group><article-title>Construction of mate pair full-length cDNAs libraries and characterization of transcriptional start sites and termination sites</article-title><source>Nucleic Acids Res</source><year>2014</year><volume>42</volume><fpage>e125</fpage><pub-id pub-id-type="doi">10.1093/nar/gku600</pub-id><?supplied-pmid 25034687?><pub-id pub-id-type="pmid">25034687</pub-id></element-citation></ref><ref id="CR46"><label>46.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Quinlan</surname><given-names>AR</given-names></name><name><surname>Hall</surname><given-names>IM</given-names></name></person-group><article-title>BEDTools: a flexible suite of utilities for comparing genomic features</article-title><source>Bioinformatics</source><year>2010</year><volume>26</volume><fpage>841</fpage><lpage>2</lpage><pub-id pub-id-type="doi">10.1093/bioinformatics/btq033</pub-id><?supplied-pmid 20110278?><pub-id pub-id-type="pmid">20110278</pub-id></element-citation></ref></ref-list></back></article>